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Abstract 
This study was carried out in Radiation and Isotopes Centre 
Khartoum (RICK). Fifty samples were collected randomly during 
February-August 2006 from cancers patients with infected wounds and 
abscesses in Radiation and Isotopes Center. The samples were collected 
from 21(42%) adult females, 16 (32%) adult male and 13(26%) 
children. All samples were cultured onto blood agar medium and 
incubated aerobically at 37 oC. Forty seven samples revealed growth of 
bacteria, while three samples did not reveal any growth of bacteria. 
The bacterial isolates obtained in this study were identified 
according to their cultural characteristic, cell morphology, Gram 
staining reaction and their biochemical properties.  
The total number of recovered isolates was sixty four.  The isolates 
were Pseudomonas spp 17 (26.6%), Proteus spp 5 (7.8%), Escherichia 
coli 9 (14%), Klebsiella spp 7 (10.9%), Staphylococcus aureus 20 
(31.2%), Staphylococcus epidermidis 2 (3.1%), Staphylococcus 
saprophyticus 1(1.6%) and Streptococcus spp 3 (4.7%).  
The isolates were subjected to antimicrobial susceptibility testing 
by disc diffusion method on Mueller Hinton medium using commercial 
antibiotics discs. The Staphylococcus aureus isolated in this study 
showed high resistance to Penicillin (100%), Ampicillin (100%), 
Tetracycline (90%) and 4 (20%) isolates showed very high resistance to 
the eight antimicrobial examined in this study. The streptococcus 
isolates were completely sensitive to Gentamicin (100%) and 
Streptomycin (100%) and showed variable sensitivity to other 
antibiotics. Escherichia coli isolates showed resistance to Cotrimoxazol 
(77.8%), Ampicillin (77.8%) and showed variable sensitivity (44.4-
77.8%) to other antibiotics examined in this study. Pseudomonas 
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isolates of this study revealed very high resistance to the Gentamicin 
(100%), Ampicillin (100%), Cotrimoxazol (100%), Nalidixic acid 
(100%), Nitrofourantion (100%), Streptomycin (94.3%), while they 
showed poor sensitivity to Gentamicin (23.5%). Klebsiella spp isolated 
in this study were sensitive to Gentamycin (85.7%) and Streptomycin 
(71.4%) and showed variable resistance (57.5-100%) to other 
antibiotics. The Proteus isolates were highly sensitivite to Gentamycin 
(100%) and Sterptomycin (80%) and showed variable resistance (40-
80%) to other antibiotics. 
The most potent antibiotics against the bacterial species isolated 
from infected wounds in this study was Gentamicin. The sensitivity of 
the isolates to Gentamicin varied from 23.5% to 100%. 
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  ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ
 -اﺟﺮﻳﺖ هѧﺬﻩ اﻟﺪراﺳѧﺔ ﻓѧﻰ اﻟﻤﺮآѧﺰ اﻟﻘѧﻮﻣﻰ ﻟﻠﻌѧﻼج ﺑﺎﻷﺷѧﻌﺔ واﻟﻄѧﺐ اﻟﻨѧﻮوى 
 ﻣﻦ 6002 أﻏﺴﻄﺲ -ﺧﻤﺴﻮن ﻋﻴﻨﺔ ﺟﻤﻌﺖ ﻋﺸﻮاﺋﻴﺎ ﻓﻰ اﻟﻔﺘﺮة ﻣﻦ ﻓﺒﺮاﻳﺮ . اﻟﺨﺮﻃﻮم
اﻟﻌﻴﻨѧﺎت اﻟﺘѧﻰ . ﻣﺮﺿѧﻰ اﻟѧﺴﺮﻃﺎن اﻟѧﺬﻳﻦ ﻳﻌѧﺎﻧﻮن ﻣѧﻦ اﻟﺘﻬﺎﺑѧﺎت اﻟﺠѧﺮوح واﻟﺨﺮاﺟѧﺎت
%( 62)31وﻣѧﻦ اﻻﻃﻔѧﺎل %( 23)61ﻣѧﻦ اﻟѧﺬآﻮر%( 24 )12ﺟﻤﻌѧﺖ  ﻣѧﻦ اﻻﻧѧﺎث
 درﺟѧﺔ 73ﺟﻤﻴﻊ اﻟﻌﻴﻨﺎت زرﻋﺖ ﻓﻰ وﺳﻂ اﻻﺟﺎر اﻟﻤﺪﻣﻢ وﺣﻀﻨﺖ هﻮاﺋﻴѧﺎ ﻓѧﻰ .ﻋﻴﻨﺔ
  .ﻣﺌﻮﻳﺔ
ﺳﺒﻌﺔ وأرﺑﻌﻮن ﻋﻴﻨﺔ اﻇﻬﺮت ﻧﻤﻮا ﺑﺎآﺘﻴﺮﻳѧﺎ ﺑﻴﻨﻤѧﺎ ﺛﻼﺛѧﻪ ﻋﻴﻨѧﺎت ﻟѧﻢ ﺗﻈﻬѧﺮ أى 
 اﻟﺒﺎآﺘﻴﺮﻳѧﺔ ﻓѧﻰ هѧﺬﻩ اﻟﺪراﺳѧﺔ ﺗѧﻢ اﻟﺘﻌѧﺮف ﻋﻠﻴﻬѧﺎ ﺑﻨѧﺎءا ﻋﻠѧﻰ اﻟﻤﻌﺰوﻻت. ﻧﻤﻮ ﺑﺎآﺘﻴﺮى 
   .ﻞ اﻟﺨﻠﻴﺔ، ﺻﺒﻐﺔ ﺟﺮام واﻟﺨﺼﺎﺋﺺ اﻟﺒﻴﻮآﻴﻤﺎﺋﻴﺔاﻟﺨﺼﺎﺋﺺ اﻟﺰرﻋﻴﺔ، ﺷﻜ
 02وﺗﺸﻤﻞ ( 46)وﻟﺔ ارﺑﻌﺔ وﺳﺘﻮنﺰآﺘﻴﺮﻳﺔ اﻟﻤﻌﺎت اﻟﺒوﻻﺰﻟﻠﻤﻌاﻟﻌﺪد اﻟﻜﻠﻰ 
ﻣﻦ اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ  ,2)%1.3( اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﺬهﺒﻴﺔ،ﻣﻦ %( 2.13)
اﻟﻤﻜﻮرات ﻣﻦ %( 7.4 )3  ﻣﻦ اﻟﻤﻜﻮرات اﻟﻌﻨﻘﻮدﻳﺔ اﻟﻤﺘﺮﻣﻤﺔ، 1)%6.1( اﻟﺒﺸﺮﻳﺔ، 
ﻣﻦ اﻻﺷﺮﻳﺸﻴﺎ %( 1.41 )9، اﻟﺴﻮدوﻣﻮﻧﺎس  ﻧﻮعﻣﻦ%( 6.62 )71  ،ﺒﺤﻴﺔاﻟﺴ
  .ﻣﻦ اﻟﺒﺮوﺗﻴﺲ ﻣﻴﺮاﺑﻴﻠﻴﺰ( 8.7 )5ﻣﻦ ﻧﻮع اﻟﻜﻠﻴﺒﺴﻴﻼ و %( 9.01 )7اﻟﻘﻮﻟﻮﻧﻴﺔ، 
وﻟﺔ اﺧѧﻀﻌﺖ ﻻﺧﺘﺒѧﺎر اﻟﺤѧﺴﺎﺳﻴﺔ ﻟﻠﻤѧﻀﺎدات ﺰﺟﻤﻴﻊ اﻟﺴﻼﻻت اﻟﺒﻜﺘﻴﺮﻳﺔ اﻟﻤﻌ 
ﻧﺘѧﺸﺎر وآﺎﻧѧﺖ ﻣѧﻮﻻر هﻴﻨﺘѧﻮن ﺑﻄﺮﻳﻘѧﺔ اﻻ  اﻟﺤﻴﻮﻳﺔ وﺗѧﻢ اﺳѧﺘﺨﺪام اﻷﻗѧﺮاص ﻓѧﻰ وﺳѧﻂ 
%( 001) اﻇﻬѧѧѧﺮت ﻣﻘﺎوﻣѧѧѧﺔ ﻟﻌﻘѧѧѧﺎر اﻟﺒﻨѧѧѧﺴﻠﻴﻦ اﻟﻤﻜѧѧѧﻮرات اﻟﻌﻨﻘﻮدﻳѧѧѧﺔ اﻟﺬهﺒﻴѧѧѧﺔ اﻟﻨﺘѧѧѧﺎﺋﺞ 
 ﻘﻮدﻳѧﺔ ﻨاﻟﻤﻜѧﻮرات اﻟﻌ ﻣѧﻦ %( 02)4و%( 09)واﻟﺘﺘﺮاﺳѧﺎﻳﻜﻠﻴﻦ %(  001)واﻻﻣﺒﺴﻠﻴﻦ
و . اﻇﻬѧﺮت ﻣﻘﺎوﻣѧﺔ ﻋﺎﻟﻴѧﺔ ﻟﺠﻤﻴѧﻊ اﻟﻤѧﻀﺎدات اﻟﺤﻴﻮﻳѧﺔ اﻟﻤѧﺴﺘﺨﺪﻣﺔ ﻓѧﻰ هѧﺬﻩ اﻟﺪراﺳѧﺔ 
%(   001)ﻻﺳﺘﺮﺑﺘﻮﻣﺎﻳѧѧѧѧѧѧﺴﻴﻦ اﻇﻬѧѧѧѧѧѧﺮت ﺣѧѧѧѧѧѧﺴﺎﺳﻴﺔ ﻟﻌﻘѧѧѧѧѧѧﺎر ا اﻟﻤﻜѧѧѧѧѧѧﻮرات اﻟѧѧѧѧѧѧﺴﺒﺤﻴﺔ 
 ﺎﻗﻴﺮﻟﺒﻘﻴѧﺔ اﻟﻌﻘѧ %( 7.66-3,33)واﻇﻬﺮت ﺣﺴﺎﺳﻴﺔ ﻣﺘﻔﺎوﺗѧﺔ %( 001)واﻟﺠﻨﺘﺎﻣﻴﺴﻴﻦ
واﻻﻣﺒѧﺴﻠﻴﻦ %(  8.77)اﻻﺷﺮﻳﺸﻴﺎ اﻟﻘﻮﻟﻮﻧﻴѧﺔ آﺎﻧѧﺖ ﻣﻘﺎوﻣѧﺔ ﻟﻌﻘѧﺎر اﻟﻜﻮرﺗﻴﻤѧﺎآﺰول . 
ﻟﺒﻘﻴѧﺔ اﻟﻤѧﻀﺎدات اﻟﺤﻴﻮﻳѧﺔ %( 8.77-4.44)واﻇﻬѧﺮت ﺣѧﺴﺎﺳﻴﺔ ﻣﺘﻔﺎوﺗѧﺔ %( 8.77)
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وﻣﻮﻧﺎس اﻇﻬѧѧﺮت ﻣﻘﺎوﻣѧѧﺔ ﻟﻌﻘѧѧﺎر اﻟﺒﻨѧѧﺴﻠﻴﻦ ﺳѧѧﻮدﻧѧѧﻮع . اﻟﻤѧѧﺴﺘﺨﺪﻣﺔ ﻓѧѧﻰ هѧѧﺬﻩ اﻟﺪراﺳѧѧﺔ 
، %(001)، اﻟﻜﻮرﺗﻴﻤѧﺎآﺰول %(001)،اﻟﺘﺘﺮاﺳѧﻴﻜﻠﻴﻦ %(001)،اﻻﻣﺒﺴﻠﻴﻦ%(001)
ﺑﻴﻨﻤѧѧﺎ اﻇѧѧﺮت ﺣѧѧﺴﺎﺳﻴﺔ %( 3.49)، اﻻﺳﺘﺮﺑﺘﻮﻣﺎﻳѧѧﺴﻴﻦ %(001)اﻟﻨﺎﻟﻴﺪآѧѧﺴﻴﻚ اﺳѧѧﻴﺪ 
ﻧѧѧﻮع اﻟﻜﻠﻴﺒѧѧﺴﻴﻼ اﻇﻬѧѧﺮت ﺣѧѧﺴﺎﺳﻴﺔ ﻟﻌﻘѧѧﺎر %(. 5.32)ﺿѧѧﻌﻴﻔﺔ ﻟﻌﻘѧѧﺎر  اﻟﺠﻴﻨﺘﺎﻣﻴѧѧﺴﻴﻦ 
واﻇﻬѧѧﺮت ﻣﻘﺎوﻣѧѧﺔ ﻣﺘﻔﺎوﺗѧѧﺔ %( 4.17)واﻻﺳﺘﺮﺑﺘﻮﻣﺎﻳѧѧﺴﻴﻦ%( 7.58)ﻦاﻟﺠﻴﻨﺘﺎﻣﻴѧѧﺴﻴ
و اﻟﺒﺮوﺗﻴﺲ ﻣﻴﺮاﺑﻴﻠﻴѧﺰ اﻇﻬѧﺮت ﺣѧﺴﺎﺳﻴﺔ . ﻟﺒﻘﻴﺔ اﻟﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ %( 001-5.75)
واﻇﻬѧﺮت ﻣﻘﺎوﻣѧﺔ ﻣﺘﻔﺎوﺗѧﺔ %( 08)واﻻﺳﺘﺮﺑﺘﻮﻣﺎﻳѧﺴﻴﻦ %( 001)ﻟﻌﻘﺎر اﻟﺠﻴﻨﺘﺎﻣﻴﺴﻴﻦ 
  . ﻟﺒﻘﻴﺔ اﻟﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻰ هﺬﻩ اﻟﺪراﺳﺔ%( 08-04)
ر اﻟﺠﻴﻨﺘﺎﻣﻴﺴﻴﻦ آﺎن أآﺜﺮ اﻟﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ ﻓﺎﻋﻠﻴﺔ ﺿѧﺪ أﻧѧﻮاع اﻟﺒﺎآﺘﺮﻳѧﺎ ﻋﻘﺎ
وﺣѧѧﺴﺎﺳﻴﺔ اﻷﻧѧѧﻮاع اﻟﺒﺎآﺘﻴﺮﻳѧѧﺔ . ﻓѧѧﻲ هѧѧﺬﻩ اﻟﺪراﺳѧѧﺔ اﻟﻤﻌﺰوﻟѧѧﺔ ﻣѧѧﻦ اﻟﺠѧѧﺮوح اﻟﻤѧѧﺼﺎﺑﺔ 
   %.  001إﻟﻰ % 5.32اﻟﻤﻌﺰوﻟﺔ ﺗﺮواﺣﺖ ﺑﻴﻦ 
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Introduction 
Infection is the process by which microbes or microorganisms 
(germs) of various types (bacteria, viruses, protozoa, and fungal 
organisms) enter the body, multiply, and damage tissues, resulting in 
illness. Having cancer and undergoing certain types of cancer treatment 
can increase a person's risk of developing an infection (Schafer, 1998).  
Patients with cancer who undergo treatment with chemotherapy, 
radiation, or surgery are at significant risk for infection. This risk is 
related to compromised host defenses and sequelae of treatment due to 
absence of neutrophils, infection barrier disruption, and shifts in 
microbial flora. The mortality attributed to infections has decreased over 
the years because of the development of β-lactam and fluoroquinolone 
antibiotics, the increased use of prophylactic antifungal and antiviral, and 
the use of colony-stimulating factors in selected patients. In response to 
more effective drug therapy, the types of infections have changed as 
resistant and opportunistic organisms emerge. Strategies to minimize and 
prevent infection in patients with mild to moderate short-term 
neutropenia are generally successful. However, complete prevention or 
elimination of infection has not been accomplished in high-risk patients 
such as those undergoing stem cell transplantation or intensive 
chemotherapy (Freifeld et al.,1997). 
In the Sudan few studies have discussed the problem of infection in 
patients with cancer. This study focus mainly in cancer wound infection 
while, most of previous studies focus in cancer infection as general.  
 XVII
 In Radiation and Isotope Center prescription of antibiotics by 
physicians based mainly on clinical signs and diagnosis made without 
referring the patients to the microbiology lab. This may lead to increase 
complication of infection and delay curing of patient and it may lead to 
increase morbidity and mortality rate due to prescription of wrong 
antibiotics. 
The objectives of the study 
• To isolate and identify the aerobic bacteria associated with wound 
infections in patients with cancer. 
• To determine the prevalence of bacterial wound infection in 
cancer patient. 
• To evaluate the efficacy of the antibiotics commonly used in the 
treatment of wound infection in patients with cancer. 
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Chapter One 
Literature Review 
1.1 Incidence in cancer 
Fever in patients with cancer can be due to infection (80%) or the 
cancer itself (20%) (Freifeld et al., 1997). The risk of infection is directly 
related to the depth and length of neutropenia or lowered white blood cell 
count. More than 60% of patients with neutropenia will become infected 
if the absolute neutrophil count is <100/mm (Sugar, 1990), approximately 
20% of febrile patients will have a documented bacteremia (Hughes et 
al., 1990). Most infections are due to bacteria. Fatal infections are usually 
due to fungal infections (Sugar, 1990). 
 1.2 Impact on quality of Life 
The impact of infection may be minimal to severe. During a period 
of short-term neutropenia, activities may be restricted to avoid crowds or 
individuals with infection. Strategies to decrease colonization of bacteria, 
such as diet changes and extra attention to personal hygiene, cause 
minimal interruption in normal routines (Freifeld et al., 1997). 
The hospitalized patient who develops fever or the patient who is 
admitted for treatment of infection is generally confined to his or her 
room. Visitors and diet are restricted, and intravenous antibiotic therapy 
must be endured. There is close monitoring and frequent reassessment of 
the patient until the fever and neutropenia resolve (Freifeld et al., 1997). 
Although studies have addressed quality of life issues for patients 
undergoing treatment for cancer, none has specifically addressed the 
impact of infection (Osoba, 1994). The use of expensive hematopoietic 
growth factors to decrease the risk of infection has led to studies of the 
cost-effectiveness of this therapy. The debate has focused on the cost of 
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inpatient treatment of infection rather than the effect of hospitalization on 
quality of life (Gleeson, 1992). The assumption is that most patients are 
willing to endure the short-term toxicity of therapy in the hope of 
achieving a sustained remission of cure (Gleeson, 1992). 
1.3 Etiology 
The etiology of infection in cancer is multifactorial. The 
immunocompromised individual may have multiple defects that are 
variable across the treatment continuum. In general, the patient 
experiences defects related to the disease in combination with a variety of 
insults related to the treatment for the disease (Schimpff et al., 1992). 
1.3.1 Malignancy-related immunosuppression 
Certain malignancies cause specific defects in the immune response; 
resulting in increased risk for infection (Lee et al., 1993).Bone marrow 
infiltration with leukemic cells results in decreased numbers and altered 
functioning of neutrophils. Humoral immunity is modified in patients 
with chronic lymphocytic leukemia or multiple myeloma, causing them to 
be at risk for respiratory infections with encapsulated bacteria such as 
Streptococcus pneumoniae or Haemophilus influenzae. When cellular 
immunity is impaired, as in patients with Hodgkins’ disease, acute 
leukemia or those undergoing stem cell transplantation, viral and fungal 
infections are common. Advanced lung cancer and intracranial tumors are 
associated with an impaired ability to respond to pathogens (Lee et al., 
1993). 
1.3.2 Treatment-related infection 
The nature, duration, and sequence of therapy for cancer influence 
the risk of infection. When bone marrow production is interrupted by 
chemotherapy, there is a decrease in the number of white blood cells, red 
blood cells, and platelets. Short-term neutropenia is defined as lasting less 
than a week while long-term neutropenia exceeds 1 to 2 weeks (Lee et 
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al., 1993). Although patients with fever and short-term neutropenia are 
usually treated with intravenous antibiotics, they quickly respond to the 
intervention and can be discharged to home (Lee et al., 1993). Patients 
receiving higher dose chemotherapy, such as those undergoing bone 
marrow or peripheral stem cell transplantation, have much longer periods 
of neutropenia and are at risk for more serious infections. 
Some chemotherapeutic agents are stomatotoxic, causing ulceration 
and breaks in the oral and gastrointestinal mucosa. These breaks allow 
bacterial translocation, which is the movement of endogenous flora into 
the bloodstream (Carter, 1994). Radiation therapy may damage skin 
integrity causing open, weeping skin (McDonald et al., 1994). The 
gastrointestinal mucosa can be damaged as well. Radiation to sites of 
active bone marrow, such as the sternum, pelvis, or long bones, may 
result in depressed hematopoiesis. 
Corticosteroids used in many treatment protocols further suppress 
immune function and mask signs and symptoms of infection. The 
numbers of white blood cells are decreased, and their function is 
impaired. In addition, corticosteroids can diminish neutrophil adherence 
to epithelial cells, blocking the first step of delivery of neutrophils to the 
site of inflammation. Finally, lymphocytes, monocytes, and eosinophils 
are redistributed to extravascular spaces and away from sites of infection 
(Lee et al., 1993). Procedures such as intravenous therapy, venipunctures, 
biopsies, and catheters cause breaks in skin integrity and further assault 
the normal defenses. The infection rate associated with long-term central 
venous catheters is as high as 60%, depending on the disease and type of 
treatment (Groeger et al., 1991). The infections include exit-site 
infections, port pocket, tunnel track infection, and bacteremia. Because 
the combination of skin colonization with specific organisms such as 
Corynebacterium species, prolonged neutropenia, and skin breaks, 
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produces bacteremia and even death, some have assessed the benefit of a 
skin hygiene program to reduce the risk (Eagan et al., 1993).   
The state of immunosuppression of the person determines the actual 
risk of infection (Rubin and Ferraro, 1993). A patient who is severely 
immunosuppressed due to disease and treatment side effects can become 
infected with minimal exposure to pathogens. A delicate balance is easily 
tipped toward illness as exposure to pathogens can be quickly life-
threatening.One of the difficulties in treating neutropenic febrile patients 
is the range of organisms capable of causing infection (deLalla, 1997). 
More than half of all infections in neutropenic patients are attributed to 
colonization of organisms acquired from the local environment (Schimpff 
et al., 1992). These organisms, which are usually nonpathogenic, produce 
disease in patients who are severely immunosuppressed. 
This colonization of organisms begins with aerobic Gram-negative 
organisms. Soon after empiric antibiotics are initiated, colonization by 
Candida spp. occurs (Lee et al., 1993). Both endogenous and exogenous 
organisms contribute to the colonization. The major sources for 
colonizing organisms are food (uncooked fruits and vegetables), water, 
inhaled airborne organisms (Aspergillus), and organisms passed through 
direct contact between care-givers and the neutropenic person. 
Opportunistic infections are invasive infections caused by nonpathogens 
e.g., Pneumocystis carinii or by organisms that usually cause very 
minimal infection e.g., Herpesvirus. Once colonization has occurred, it is 
easy for microorganisms to migrate through mucosa denuded by the 
effects of chemotherapy or radiation or through specific breaks in the skin 
caused by catheters, venipunctures, or other procedures. 
In the 1960s and 1970s, the predominant organisms causing 
infection in neutropenic persons were Gram-negative pathogens 
(Schimpff et al., 1992). Gram-negative sepsis was frequently life-
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threatening since the broad-spectrum antibiotics used e.g., 
Carboxypenicillin first-generation Cephalosporins, and Aminoglycosides, 
were less effective than those used today e.g., third-generation 
Cephalosporins, Fluoroquinolones, and Antifungals. In addition, less 
serious Gram-positive infections are more prevalent now (Freifeld, 1993) 
this change in the type of infecting organisms and improved antibiotic 
therapy allows for the consideration of antibiotic monotherapy and 
shorter courses of combination therapy in appropriately identified low-
risk persons (deLalla, 1997). 
1.4 Pathophysiology 
The pathogens responsible for infections in patients with cancer are 
divided into two groups: (1) those responsible for the initial infection and 
(2) those responsible for second or subsequent infection (Wade, 1993). 
Bacterial infections quickly develop in the neutropenic person and 
account for 85% to 90% of the pathogens associated with febrile 
neutropenia (Pizzo et al., 1982). The organisms generally arise from the 
endogenous flora colonizing the skin, respiratory, genitourinary, and 
gastrointestinal tracts (Freifeld, 1993). Breaks in the integrity of the 
mucosa caused by the effects of chemotherapy or intravenous catheters 
allow bloodstream infections. The most serious infections and the 
primary cause of infections in neutropenic patients are Gram-negative 
organisms, generally Enterobacteriaceae or Pseudomonas aeruginosa. 
In the 1970s, Gram-positive infections with Staphylococcus spp., 
Streptococcus spp., Corynebacteria, and Clostridia spp. have increased 
(Pizzo et al., 1982) because of common use of implanted catheters and 
the increased use of prophylactic antibiotics (Rubin and Ferraro 1993). A 
catheter-associated infection is diagnosed when there are positive blood 
cultures from both a catheter lumen and a peripheral venipuncture (Lee et 
al., 1993).  
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Bacterial pneumonia is a common infection in immunocompromised 
persons due to a combination of variables (Freifeld et al., 1997). Gram-
negative bacteria colonize in the upper airway. Once pneumonia 
develops, the severity is determined by the depth and length of 
neutropenia and the virulence of the organism. In addition, if the 
neutropenia continues, secondary invasion of opportunistic organisms 
may occur. 
Herpesvirus infections have a great impact on the 
immunocompromised patient as well (Rubin and Ferraro 1993).   
Included are herpes simplex virus 1 and 2 (HSV-1, HSV-2), varicella-
zoster virus (VZV), cytomegalovirus (CMV), and Epstein-Barr virus 
(EBV) (Sugar, 1990). Each of these viruses has the characteristic of 
latency; that is, a primary infection with the virus results in a lifelong 
dormant infection capable of being reactivated during a period of 
immunosuppression. Herpes simplex viruses often cause an initial 
infection in neutropenic persons. Reactivations of viral infections are 
most common in patients with hematologic malignancies and those 
undergoing stem cell transplantation (Zaia, 1990). 
If fever persists 5 to 7 days after the initiation of broad-spectrum 
antibiotics, and no source of infection has been identified, a secondary 
infection is presumed. Candida albicans is the predominant fungal 
infection in patients with solid tumors, while non-albicans Candida is 
common among patients with hematologic disorders (Viscoli et al., 
1997). A positive blood culture for Candida in a neutropenic patient is 
considered indicative of disseminated candidiasis (Sugar, 1990). 
Cytomegalovirus and filamentous fungi (Aspergillus) are common causes 
of secondary infection in severely immunosuppressed persons (Viscoli et 
al., 1997). 
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1.5 Risk factors for infections in people with cancer  
Some people with cancer are at increased risk of infection because of 
the changes in their body's defense systems. Cancer and treatments for 
cancer can affect these systems in many different ways. Two common 
consequences of cancer and cancer treatments are immunosuppression (a 
weakened immune system) and myelosuppression (insufficient 
production of blood cells by the bone marrow) (Carter, 1994).  
1.5.1 Tumor-associated abnormalities  
The growth of tumors through the surface of the skin and mucous 
membranes can disrupt these natural barriers and provide a way for germs 
to enter the body. The cancer can also invade and replace the normal cells 
in the bone marrow. The cancer cells then compete with the normal bone 
marrow cells for nutrients and finally destroy them. If too many normal 
marrow cells are destroyed or replaced, the remaining marrow cells will 
not be able to produce enough infection-fighting WBCs. Cancer can also 
alter the function of the immune system without invading the bone 
marrow. Tumors may compress nearby normal tissues or reduce blood 
flow to the normal tissues by putting pressure on blood vessels. Tumor 
masses in the lungs may obstruct normal drainage of mucus with resultant 
infections. Normal tissues damaged in these ways are more susceptible to 
infections (Carter, 1994). 
Cancer cells can also release substances that interfere with the proper 
functioning of immune system cells. This is a well-known effect of many 
cancers that develop from immune system cells (such as lymphomas, 
leukemias, and multiple myeloma), but can occur with other cancers as 
well, especially if they are large and have spread extensively (Carter, 
1994).   
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1.5.2 Surgery  
Any type of major surgery can cause immunosuppression, but the 
reason for this is not totally clear. Within hours of surgery, researchers 
have noted decreases in immune function. Anesthetic agents may play a 
role in reducing normal immunity. The time for complete immune system 
recovery may take 10 days to several months. Also, surgery often disrupts 
the skin and mucous membranes and exposes internal tissues to germs, 
thereby placing a person at an increased risk for infection (Dean et al., 
1996).  
Surgery is commonly used to diagnose, stage, and treat people with 
cancer. Factors that increase the risk of infection after surgery include the 
length of hospitalization, the extent of the surgery, the duration of the 
operation, the amount of bleeding during surgery, the nutritional state of 
the person, prior cancer treatment such as chemotherapy or radiation of 
the surgical area, and other medical problems a person may have, such as 
diabetes. People with cancer may be given antibiotics before surgery to 
decrease their risk of infection. The wound caused by surgery is a 
common site of infection. Because surgery is a common treatment for 
people with cancer, it is important to be aware of the chance of infection 
after surgery (Dean et al., 1996). 
1.5.3 Chemotherapy  
Chemotherapy is the most common cause of immunosuppression (a 
weakened immune system) and myelosuppression (insufficient 
production of blood cells) in people receiving cancer treatment. The 
severity of immunosuppression and myelosuppression depends on the 
specific chemotherapy drugs used, the dosage, the schedule, previous 
treatments for cancer, age, nutritional status, type of cancer, and the stage 
of the cancer. Some drugs have a greater effect on the bone marrow than 
others do. When chemotherapy drugs are said to be myelosuppressive, this 
 9
usually means that the drug affects production of all blood cells. 
However, drugs may have different effects on the production of white 
blood cells, red blood cells, and platelets. Generally, white blood cell 
production is the most sensitive to chemotherapy drugs (Dean et al., 
1996). 
1.5.4 Radiation therapy  
The effects of radiation therapy on the cells of the bone marrow are 
similar to the effects of chemotherapy. Specifically, people may develop 
leukopenia or neutropenia, which will increase their risk for infections. 
Several factors affect the degree of leukopenia from radiation therapy. 
These include the total radiation dose, the radiation schedule, and the 
volume of productive blood cells that is directly in front of the radiation 
field (in other words, how much of the body is irradiated). Unless people 
receive total body irradiation (TBI), they generally do not experience 
extremely low blood counts. This is because radiation is usually given to 
just one area of the body, while chemotherapy is systemic (travels 
throughout the body). However, depending on the dose and type of 
radiation, the skin and mucous membranes may be damaged, making 
them less effective in keeping germs away from internal organs. 
Radiation treatments are given over many scheduled sessions rather than 
one large dose. This has helped to decrease the amount of 
immunosuppression and risk of infections (Dean et al., 1996).  
1.5.5 Biotherapy  
Biotherapy, also known as biologic therapy or immunotherapy, is 
intended to strengthen the immune system's ability to recognize and 
attack cancer cells. Although these treatments stimulate immune reactions 
against cancer cells, they sometimes interfere with immunity against 
infections. People who receive biological therapies may be at risk for 
immunosuppression and neutropenia. Their WBC count may drop by 
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40%-60%, but will return to normal after the therapy is stopped (Dean et 
al., 1996).  
1.5.6 Hematopoietic stem cell transplantation  
Hematopoietic stem cell transplantation (HSCT) is the term now 
used to include bone marrow transplantation (BMT) and peripheral blood 
stem cell transplantation (PBSCT). These therapies use very high doses 
of chemotherapy and/or total body irradiation (TBI) to kill the cancer 
cells. In the process of killing the cancer cells, hematopoietic (blood 
forming) stem cells of the patient's normal bone marrow are also killed. 
Stem cells removed from the patient before chemotherapy or stem cells 
from a donor are used to replace these cells. The use of intensive 
chemotherapy, sometimes combined with TBI, often causes more severe 
and prolonged neutropenia. These treatments, especially when used 
together, reduce the effectiveness of the skin and mucous membranes in 
keeping germs from entering the body. Finally, the cancers that HSCT is 
intended to destroy can also directly weaken the patient's immune system 
(Ellerhorst et al., 1997).  
1.5.7 Psychological factors  
There is little question that being diagnosed with cancer, making 
decisions about treatment options, and facing uncertainties are all very 
stressful. Research has shown that some people with cancer experience 
higher than average levels of stress, causing them to feel helpless, 
hopeless, and out of control. These people tend to be at higher risk for 
infection. The relationship of psychological factors to infection, however, 
is not clearly understood. Long periods of stress or depression can lead to 
poor nutrition that can weaken the immune system and contribute to 
infection. Research also suggests that emotional stress can affect the 
body's hormones which, in turn, can influence the immune system. 
Specific stressors include: depression, hopelessness, inability to cope, 
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lack of social support, loneliness, personal and/or family illness and lack 
of sleep and fatigue (Ellerhorst et al.,1997).  
 
1.6 Types of infections that affect people with cancer  
People with cancer may develop several types of infections. These 
types differ in their risk factors, the symptoms they cause, their prognosis, 
and how they are treated. In classifying different types of infections, it is 
often useful to consider two key aspects of the infection, the part of the 
body affected and the type of microorganism or germ responsible for the 
infection.  
1.6.1 Areas of the body affected by infections  
The area of body involved, also known as the site of the infection is 
identified by the patient's signs and symptoms (for example, localized 
pain, redness, or swelling) and the results of imaging tests (x-rays, CT 
scans, nuclear medicine scans, etc.). The common sites of infection in 
people with cancer include the skin and mucous membranes, the tissues 
surrounding a venous access device (VAD), the digestive system 
(esophagus, stomach, and intestines), the respiratory system (lungs), the 
urinary system (bladder and kidneys), and the nervous system (brain and 
spinal cord). The medical names for various types of infections often 
simply add the suffix, "itis," after the English, Latin, or Greek name of a 
tissue or organ. Knowing some of these terms can help patients 
understand their medical conditions and participate more actively in their 
own treatment decisions (Jassak et al., 1998). 
1.6.2 Types of germs that cause infections in people with cancer  
Infections are classified according to the type of microbes or germs 
that cause them. Bacteria, viruses, protozoa/parasites, or fungi may cause 
infections in people with cancer. Infections that commonly affect people 
with cancer tend to have one feature in common.  They are often caused 
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by germs that are normally present in the environment and people's 
bodies. These germs usually do not cause infections in people with 
normal protective barriers (skin and mucous membranes) and strong 
immune systems. But, if these defenses are weakened by cancer or by 
cancer treatments, these germs can begin to grow and cause damage to 
tissues. These infections are often called opportunistic infections, because 
the germs use a patient's temporarily weakened defenses as an 
opportunity to cause disease (Jassak et al., 1998).  
Staphylococcus epidemridis rarely causes infections in healthy 
people but can cause infections in people with cancer who have venous 
access devices (VADs) and a low white blood cell count. Staphylococcus 
aureus can cause very serious infections, can affect people with 
weakened or healthy immune systems, and is often resistant to many 
antibiotics. Therefore, it can be very difficult to treat (Jassak et al., 1998).  
1.7 Laboratory tests to identify germs  
Knowing the exact type of germ responsible for an infection is very 
helpful in selecting the best treatment. Different drugs are used for each 
of the main types of microbes, bacteria, viruses, fungi, and parasites. 
Even among bacteria, different types vary greatly in their sensitivity to 
different antibiotics. Doctors know which germs tend to infect which 
organs of people with cancer, and can often make an educated guess at 
which germs are probably causing a patient's infection. Often, patients 
who have experienced previous infections have recurrent infections with 
the same organism responsible for the original infection. Educated 
guesses are very important, because the most accurate tests for 
identifying germs can take several days. Because infections in people 
with cancer may progress quickly, it is often necessary to start treatment 
before testing is complete. Medication to treat an infection may be 
changed after laboratory tests have identified the specific germ.  
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Examining specimens from infected tissues under a microscope can 
also provide clues about the type of germ involved. Bacteria, fungi, and 
protozoa are large enough to see under a typical laboratory microscope 
(light microscope), although they are much too small to see without a 
microscope. Samples are usually treated with a series of stains (dyes), 
which change the color of germs and make them easier to recognize. For 
example, bacteria are tested using Gram- stain, which turns them either 
red (also called Gram-negative) or violet (Gram-positive). This test takes 
only a few minutes and its result often helps doctors choose the most 
appropriate antibiotics before laboratory test results are available. Viruses 
are too small to see using a light microscope. Although they can be seen 
under an electron microscope (which is about 1,000 times more 
powerful), this instrument is rarely used to identify germs in people with 
cancer. This type of testing takes too long and there are other ways to 
identify viruses. Viruses can often be identified by recognizing the 
changes they cause in cells they infect. Sometimes these changes can be 
recognized in cells from specimens removed directly from the patient. In 
other situations, specimens are added to test cells grown in laboratory 
dishes. If a virus is present, the test cells will undergo changes that can be 
recognized by the laboratory technologists.  
New medical laboratory tests can rapidly identify some germs based 
on analysis of their DNA, RNA, or other substances. These tests are often 
very useful in selecting the best medical treatment as quickly as possible, 
before the infection causes serious tissue damage.  
All of these tests require samples from the patient. Types of samples 
typically used include blood, urine, spinal fluid, and sputum (phlegm). If 
a patient has symptoms suggesting an infection of a particular organ, 
samples will be taken to check for germs. For example, sputum samples 
may be taken if someone has a cough and shortness of breath. Urine 
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samples may be taken from someone with blood in their urine or if they 
experience pain while urinating. Sometimes, samples will be taken when 
someone is at risk for developing infections (usually because of a very 
low WBC count). If an infection is found, treatment is started before 
symptoms occur (Jassak et al., 1998).   
1.8 Bacterial Infections 
Bacteria are responsible for the majority of the infections in people 
with cancer. Bacteria that commonly cause infections in people with 
cancer include Pseudomonas aeruginosa, Klebsiella pneumoniae, 
Escherichia coli (E. coli), Salmonella, Clostridium difficile, 
Staphylococcus aureus, Staphylococcus epidemidis, Pneumococcus, and 
Enterococcus. 
1.8.1 Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a Gram-negative, aerobic rod belonging 
to the bacterial family Pseudomonadaceae. It is an opportunistic 
pathogen, meaning that exploits some break in the host defenses to 
initiate an infection. It causes urinary tract infections, respiratory system 
infection, dermatitis, soft tissue infections, gastrointestinal infections and 
a variety of systemic infections, particularly in patients with severe burns 
and in cancer and AIDS patients who are immunosuppressed. 
Pseudomonas aeruginosa infection is a serious problem in patients 
hospitalized with cancer, cystic fibrosis, and burns. The case rate in these 
patients is 50 percent (Kennth, 2004). Pseudomonas aeruginosa, an 
increasingly prevalent opportunistic human pathogen, is the most 
common Gram-negative bacterium found in nosocomial infections. P. 
aeruginosa is responsible for 16% of nosocomial pneumonia cases 
(Wibin,1997), 12% of hospital-acquired urinary tract infections 
(Pollak,1995), 8% of surgical wound infections (Kluytman,1997), and 
10% of blood stream infections (Gorden et al., 1998). 
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Immunocompromised patients, such as neutropenic cancer and bone 
marrow transplant patients are particularly susceptible to opportunistic 
infections. In this group of patients, P. aeruginosa is responsible for 
pneumonia and septicemia with attributable deaths reaching 30% (Bergen 
and Shelhamer1996; Fergie et al., 1994). 
The bacterium is naturally resistant to many antibiotics due to 
permeability barrier afforded by its outer membrane LPS. Also its 
tendency to colonize surfaces in a biofilm form which makes the cells 
impervious to therapeutic concentrations antibiotics. Since its natural 
habitat is the soil, living in association with bacilli, actinomycetes and 
molds, it develops resistance to a variety of their naturally-occurring 
antibiotics. Only a few antibiotics are effective against Pseudomonas 
aeruginosa, including Fluroquinolones, Gentamicin, and Iimipenen, and 
even these antibiotics are not effective against all strains (Kennth, 2004). 
 1.8.2 Staphylococcus aureus 
Staphylococcus aureus are Gram-positive cocci that occur 
individually, in pairs, and in irregular grape like clusters. Naturally 
inhabit mucosal and epithelial surfaces. Other sites of colonization 
include wounds, tracheotomy and venous catheters sites. The most life 
threating is bactereimia (Tolan, 1993). The organism can cause disease by 
two mechanisms, tissue invasion and toxin production. The toxins 
liberated by the organism may have effects at sites distant from the focus 
of infection or colonization (Tolan, 1993). 
Staphylococcus aureus was the most common cause of nosocomial 
infections reported in the National Nosocomial Surveillance System 
between 1990 to 1996. The leading cause of nosocomial pneumonia and 
surgical site infections and the second leading cause of nosocomial 
bloodstream infections, S. aureus also cause community-acquired 
infections (e.g., osteomyelitis and septic arthritis, skin infections, 
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endocarditis, and meningitis). More than 95% of patients with S. aureus 
infections worldwide do not respond to first-line antibiotics such as 
Penicillin or Ampicillin (Neu, 1992). 
 1.8.3 Escherichia coli 
Escherichia coli is a Gram-negative bacillus within the 
Eterobacteriacae family. E. coli is the leading cause of urinary tract 
infections. The different strains of E. coli are identified according to three 
surface antigens, which are O antigen (part of the lipopolysaccharide on 
the surface of the bacteria), K antigen (located on the capsule), and the H 
antigen (located on the flagella). Certain strains of E. coli inhabit the 
human gastrointestinal tract without damaging the host. Pathogenic 
Escherichia coli acquired in hospitals infected wounds, urinary tract, 
peritoneum, and lungs (Elisabeth et al., 2004). 
The virulence factors of E. coli responsible for nosocomial infections 
have been completely identified, and many of the identified factors are 
also responsible for community acquired E. coli infections. Although E. 
coli can be responsible for up to 50% of nosocomial pneumonia in 
hospitals, their virulence factors have not been identified. 
E. coli is able to proliferate in hospital because of its resistance to 
multiple antibiotics (Elisabeth et al., 2004). 
1.8.4 Proteus mirabilis 
P. mirabilis is a Gram-negative facultative anaerobe. Normally 
found in the gastrointestinal tract. P. mirabilis is a part of the normal 
microflora of a healthy individual. However, P. mirabilis is an 
opportunistic pathogen that can colonize the bladder, surgical wound, 
lungs, and the urinary tract (Beck et al., 1994). 
Coliforms and Proteus species rarely cause extra intestinal disease 
unless host defenses are compromised. Disruption of the normal intestinal 
flora by antibiotic therapy may allow resistant nosocomial strains to 
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colonize or overgrow. The skin and mucosa may be breached by disease, 
trauma, operation, venous catheterization, tracheal intubation, etc. 
Immunosuppressive therapy also increases the risk of infection 
(Bergeron, 1995). 
1.8.5 Enterobacter species 
Enterobacter species are nosocomial pathogens responsible for a 
variety of infection. There are 11 specific species of the Enterobacter 
genus, but Enterobacter aerogenes and enterobacteriaceae are the most 
prevalent among human related infections. The species itself rarely 
causes infection in a immuoncompromised patients. It is responsible for a 
wide variety of infections, including bacteremia, skin infections, 
endocarditis, osteomyelitis, and opthamalic infections. These pathogens 
can cause mortality in patients, especially infants and the elderly and even 
more complicated by antibiotic resistance (Elisabeth et al., 2004). 
1.8.6 Acinetobacter species 
Acinetobacter is species that has emerged as a rather common cause of 
nosocomial infections among immunocompromised hosts. It is distributed 
widely in nature and can be found in soil, fresh water, sewage, fresh 
meat, poultry, contaminated milk, and frozen food. It is usually found in 
the flora of the skin, wound and surgical sites, and along the respiratory 
tract. From these positions a number of infections can occur, including 
meningitis and pneumonia. Acinetobacter strains can be part of the 
bacterial flora of skin of healthy individuals and skin can even be a 
reservoir for infections of immunocompromised patients and medical 
staff (Elisabeth et al., 2004). Even through it is resistant to some 
antibiotics it can be still treated with aminoglycosides, and preventive 
measures in isolating outbreaks and education of risk reduction can 
reduce this type of infection (Beck et al., 1994). 
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1.8.7 Streptococcus pyogenes 
Streptococcus pyogenes is a Gram-positive, non-motile, 
nonsporeforming coccus that occurs in chains or in pairs of cells. 
Streptococcus pyogenes is one of the most frequent pathogens of humans 
and is successful in its infection mechanisms because it is able to colonize 
and quickly multiply while surviving defense and impacting the immune 
system negatively. With this invasion of bacteria into vulnerable tissues, a 
variety of suppurative infections normally occur, including puerpal fever, 
pharyngitis, and severe invasive infections. Treatment is successful 
through antibiotics, more specifically Penicillin, yet no effective vaccine 
has been produced (Bergeron, 1995). 
1.8.8 Klebsiella pneumoniae 
The human gastrointestinal tract is host of a large number of colonic 
microflora. Essential to normal bowel health and function, many of these 
organisms reside in the colon in a commensal form. Normally found in 
the colon, Klebsiella does not present a problem to human. However, 
when it escapes the confines of colon, Klebsiella has the ability to cause 
illness. Generally Klebsiella infections occur in people who have 
weakened immune systems. Due to this fact, Klebsiella often appears in 
nosocomial infections acquired when a person is exposed to hospital 
environment. The most clinically important species of this genus, 
Klebsiella pneumoniae, is capable of causing several health 
complications (Elisabeth et al., 2004). Klebsiella pneumoniae tends to 
affect people with underlying disease such as diabetes and chronic lung 
disease. Although Klebsiella pneumoniae can cause severe pneumonia 
both inside and outside the hospital, in nosocomial cases, it more 
commonly causes urinary tract infections or burn wound infections. The 
pneumonia caused by Klebsiella is characterized by a high fever, chill, 
chest pain and a cough associated with thick, bloody sputum 
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(hemoptysis). Mortality rates due to Klebsiella pneumoniae are elevated 
because it is frequently destructive to the lungs and can cause the 
formation of pus pockets (or abscesses) and subsequent scar tissue, 
therefore compounding the bacterial infections with the patient's 
underlying disease (Bergeron, 1995). 
Klebsiella pneumoniae also causes less severe respiratory infections 
such as bronchitis. Further, it can cause urinary tract infections in 
catheterized patients (making it second only to Escherichia coli as a 
urinary tract infectious pathogen) and bacteremia in the blood. Invasive 
treatment such as intravenous catheters for administration of fluids, 
catheter in the bladder for urine drainage, and breathing tubes for patients 
in breathing machines provide passage into the bodies of patients with 
weakened immune systems, thus increasing the susceptibility to infection. 
If not treated aggressively early in onset, all of these infections can lead 
to shock and death (Bergeron, 1995). 
1.8.9 Clostridium difficile  
Clostridium difficile is the major causative agent of inflammation of 
the colon (colitis) and diarrhea that occur from taking antibiotics and 
nosocomial exposure. It is primarily acquired in hospitals and chronic 
care facilities following the administration of broad-spectrum antibiotics 
and it's thought to be the most frequent cause of nosocomial diarrhea 
outbreaks. The organism and its spores have been found in hospitals 
environments such as toilets, telephones, stethoscope, and the hands of 
health-care worker (Elisabeth et al., 2004). 
Clostridium difficile has been reported to cause colitis with the use 
of virtually all antibiotics and some antiviral and antifungal drugs. It most 
commonly occurs with the use of Penicillin, Ampicillin, Amoxicillin, 
Cephalosporin, and Clindamycin. Elderly patients, patients with the 
colonic diseases (i.e. inflammatory bowl disease, colorectal cancer, etc) 
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or other underlying diseases are the most at risk for Clostridium difficile 
infections (Elisabeth et al., 2004). 
1.9   Fungal infections  
In humans, fungi can live in balance with other microbes that 
normally colonize the body without causing symptoms or tissue damage. 
However, a fungal infection can occur when there are changes in this 
balanced environment, such as damage to the skin or mucous membranes, 
low WBC counts, immunosuppression, and decreased bacteria normally 
found on the body’s surfaces (which may occur as the result of antibiotic 
treatment). Fungal infections can be serious and even fatal. Fungi that 
commonly infect people with cancer include Candida (yeast), 
Aspergillus, Cryptococcus, Histoplasma, Phycomycetes, and 
Coccidioides (Sugar, 1990).  
Candida is the most common cause of fungal infection. It can be 
present in a healthy individual without causing any problems, or it may 
cause a mild skin rash or vaginal discharge. But an immunosuppressed 
person is at risk for a much more serious infection that can affect the 
mouth and digestive system and may even spread to other organs.  
Aspergillus is a fungus that is often found in the air and in our 
environment. It is rarely a problem in healthy people but it can cause 
serious infections of the lungs, kidneys, brain, and heart valves in 
individuals with cancer, especially those with very low WBC counts 
and/or patients receiving immunosuppressive cancer treatments. This type 
of infection is often difficult to diagnose and often requires aggressive 
treatment as soon as it is suspected (Viscoli, 1997). 
Cryptococcus, which is found in the soil and in pigeon waste, is 
often spread by breathing in the organism. In otherwise healthy people, it 
often causes a lung infection that resolves without ever causing 
symptoms. However, the fungus can remain inactive in the lungs for 
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many years. If the person’s immune system becomes weakened years 
later (as a result of cancer therapy, for example), it can grow and spread 
to other parts of the body. One of the most serious consequences of this 
infection is meningitis (infection of the membranes that surround the 
brain and spinal cord) (Viscoli, 1997).  
Histoplasma is another fungus that often infects the lungs of healthy 
people without causing any symptoms or tissue damage. People become 
infected through contact with soil contaminated by bird or bat waste. Like 
cryptococcus, the fungus may remain inactive for many years in the lungs 
of otherwise healthy people, but can become reactivated if their immune 
system becomes weakened. In people with cancer, histoplasma may cause 
a serious lung infection and may spread to the lymphatic system, liver, 
and spleen.  
Phycomycetes (Mucor, Phizopus, and Absidia) are fungi that are 
present in the dust and air. The lungs, nasal sinuses, and gastrointestinal 
tract are the major sites for infection. In people with serious immune 
system problems, nasal sinus infections can spread to the brain and lungs. 
This infection invades blood vessels and is difficult to control. 
Coccidiodes is present in the soil of the southwest part of the US and 
enters the lungs when people breathe it in. Healthy people often become 
infected but may not have symptoms. Fever and chest pain may be 
symptoms but rarely occur. People with a weakened immune system are 
susceptible to serious infections of the lungs, skin, and brain (Sugar, 
1990).   
1.10   Viral infections  
Most viral infections in people with very low WBC counts are 
caused by herpes simplex virus (HSV, the virus that causes cold sores and 
genital herpes), varicella-zoster virus (VZV, the chickenpox virus), and 
cytomegalovirus (CMV) (Zaia, 1990).   
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Varicella-zoster can cause serious infections in people with cancer, 
especially children. Unlike chickenpox infections in healthy people, VZV 
infections in people with cancer can be fatal. Unlike many other 
infections, VZV infection is never completely cured. When healthy 
people recover from chickenpox, some of the virus remains inactive in 
their nerve cells. If the person's immune system is weakened years later 
as a result of cancer, the virus can be reactivated causing a condition 
known as shingles. People with this condition have clusters of tiny, 
painful blisters along the path of nerves on the skin. Although these skin 
blisters are painful, the most serious aspect of VZV infection in people 
with a weakened immune system is that the virus may spread to other 
organs, resulting in pneumonia and encephalitis (infection of the brain). 
Varicella is very contagious so the risk of spreading it to a person who 
has not had it before or has not been immunized is high. The risk of 
serious tissue damage from the infection is high among people with low 
WBC counts and patients whose immune systems are weakened by 
cancer (especially Hodgkin's disease and non-Hodgkin's lymphoma) 
(Zaia, 1990).  
Herpes simplex virus is related to varicella-zoster. Like VZV, HSV 
causes mild infections in people with a healthy immune system, but can 
remain inactive in nerve cells and become reactivated if the person 
develops cancer years later. Like VZV, HSV can also cause pneumonia 
and encephalitis.  
Cytomegalovirus (CMV) infection is a common cause of pneumonia 
among people with immune systems weakened by cancer or bone marrow 
transplantation. CMV infection in otherwise healthy people is usually not 
serious. But, in people with weak immune systems, CMV can cause 
serious pneumonia and retinitis, a serious eye infection that can lead to 
blindness if not treated (Tolan, 1993).  
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1.11   Protozoal infections  
Most protozoal infections affect people with decreased immunity, 
resulting from organ transplantation, cancer, AIDS, or other diseases. 
These organisms cause few problems in the person who has a normal 
immune system, but in the immunosuppressed person, these infections 
are often difficult to treat and can be life-threatening. Common protozoa 
that can infect people with cancer include Pneumocystis carinii, 
Toxoplasma, and Cryptosporidium (Rubin and Ferraro1993). 
Pneumocystis carinii is usually classified as a protozoan based on its 
appearance under a microscope (even though its DNA, RNA, and other 
chemical components more closely resemble those of a fungus). It 
typically causes pneumonia, and only rarely spreads to other organs.  
Toxoplasma gondii is found in soil, cat waste, and undercooked 
meats. This protozoan can cause fever and lymph node swelling in people 
with a normal immune system. But, when the infection affects people 
with a severely weakened immune system, it may spread to and damage 
the brain and heart.  
Cryptosporidium is a common cause of enteritis (intestinal infection) 
in immunosuppressed people. It is spread by infected people and animals 
and by drinking contaminated water. It can cause watery diarrhea, 
malnutrition, imbalances of minerals in the blood, and dehydration 
(Rubin and Ferraro1993). 
1.12 Prevention and treatment of infections in people with cancer  
General precautions and early recognition of infections  
Infection is one of the most common life-threatening complications 
of cancer. Therefore, it is very important that people with cancer take 
precautions to reduce their risk of infection and remain alert to early signs 
of infection. Treatment can then be started as early as possible. This 
advice is especially important for patients with neutropenia. Signs and 
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symptoms of an infection include: body temperature of more than 100.5o 
F, orally, sore throat, cough or shortness of breath, nasal congestion, 
burning during urination, shaking chills and redness, swelling, or warmth 
at the site of an injury, surgical wound, or vascular access device (VAD).  
Fever is especially important because it is often the first sign of an 
infection in people with cancer. Usually patients are instructed to call 
their doctor or nurse if they have a fever greater than 100.5o F or other 
signs and symptoms of infection.  
It is important for individuals with cancer and their families and 
friends to be aware of the following: The patient's risk for infection, the 
function of WBCs, the expected duration of a low WBC count, how 
infections are transmitted, the importance of taking the patient's 
temperature, how to take it accurately, and how often, when to report a 
fever or other signs and symptoms of infection to the doctor or nurse, the 
importance of basic handwashing and hygiene practices for the patient 
and those they come in contact with, the importance of cleaning the 
perianal area well after each stool and urination, how to perform good 
oral care and check for mouth sores and fungal infections, where to look 
for signs of infection (skin, mouth, VAD sites), good care of VADs. the 
importance of good nutrition, a balanced diet, and drinking plenty of 
fluids, the importance of sleep and exercise and how to conserve energy, 
the importance of avoiding crowds and people with illnesses when at risk 
for infection, the need to avoid contact with bird, cat, dog, and fish 
droppings, fresh flowers, and raw fruits and vegetables (these have high 
levels of bacteria and fungi), the importance of avoiding all stagnant 
water (like water in vases, denture cups, soap dishes), the importance of 
taking medications as prescribed and being sure your doctor is aware of 
all medications you are taking (prescription or over-the-counter), 
measures to prevent dryness of the skin and mucous membranes (use 
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lotion, use a vaporizer for humidity) and the need to talk with your doctor 
before receiving any immunizations and before closed contact with 
children or adults who have recently been immunized (Osoba, 1994). 
1.12.1 Immunizations  
Fatal infections caused by measles, polio, and small pox have 
occurred as a result of live virus vaccines given to patients with impaired 
immune function. Inactivated polio vaccines should be given to children 
who have immunosuppression and to their siblings and other household 
contacts, because oral polio virus vaccine strains (which contain a live 
virus) can be transmitted to immunosuppressed people. Live virus 
vaccines can be administered at least 3 months after all 
immunosuppressive therapy has stopped but the time frame varies.  
People who are seronegative for the chickenpox virus and have been 
exposed to people with chickenpox should receive VZV immune globulin 
immediately and no later than 72 hours after exposure. Cancer therapy 
may be stopped and restarted after the end of the incubation period, 
usually about 21 days. When signs or symptoms of VZV infection appear 
in a person with cancer, cancer therapy that is immunosuppressive may 
be withheld until skin lesions have dried and form scabs (Zaia.1990). 
1.12.2 Prophylactic antibiotics  
Routine use of oral or intravenous antibiotics in people with severe 
neutropenia can help reduce their risk of infections. Recent studies have 
found oral antibiotics to be as effective as intravenous treatments, in 
addition to being more convenient and less expensive (Wade, 1993). 
1.12.3Use of hematopoietic growth factors (Colony stimulating factors)  
Colony-stimulating factors (CSFs), also known as hematopoietic 
growth factors, are natural body proteins that influence the growth and 
formation of blood cells, including WBCs. Several of these CSFs are 
available to give to patients with a low WBC count to prevent or treat 
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infections. An example of a single cell line product is filgrastim 
(Neupogen) which affects neutrophils, a type of WBC. Sargramostim 
(Leukine) is an example of a multiline product which affects neutrophils 
and monocytes/macrophages. These agents have been shown to decrease 
the duration and severity of neutropenia and leukopenia in selected 
groups of patients; they can reduce the risk of infection (Wade, 1993).  
1.13 Treatment of infections in people with cancer  
Fever and other signs and symptoms of infection in a person with a 
severely weakened immune system are considered a medical emergency. 
Antimicrobial medications need to be started immediately. After a 
complete physical exam, laboratory tests will be done to try to determine 
the specific organism causing the infection and the location of the 
infection. Antimicrobial medications, most often antibiotics, are started 
before laboratory test results are complete. Once the specific organism is 
identified, a different medication may be given. In the past, patients were 
almost always admitted to the hospital for treatment of these infections 
and many still are. Today some patients are receiving oral antibiotics or 
intravenous antibiotics in outpatient clinics, doctor's offices, or at home 
(Lee, 1993).  
In addition to treatment with medications, nutrition counseling and 
stress management may help increase the immune function of individuals 
with cancer and may prevent infections. Nutrition counseling should 
include the importance of a high intake of calories, protein, and vitamins. 
In particular a low microbial diet is suggested. Patients should avoid 
uncooked herbs and spices, raw fruits and vegetables, cold cuts, raw eggs, 
undercooked meats, and soft cheeses. Such therapies as biofeedback, 
humor, music therapy, guided imagery, counseling, and medictation may 
be helpful for stress management and may have a positive effect on the 
immune system (Lee, 1993).  
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1.13.1 Bacterial infections  
When treating bacterial infections, antibiotic therapy is started after 
specimens for laboratory tests have been taken but before these tests 
results have identified the organism. Antibiotics are selected based on the 
likely microbe involved and the site of infection. Most often, antibiotics 
are chosen that cover a broad spectrum of bacteria. Sometimes a few 
antibiotics are combined. Excessive use of antibiotics is avoided, 
however, because this can cause some bacteria to develop resistance to 
these drugs. For example, some strains of Staphylococcus are resistant to 
most antibiotics that can be given by mouth, so intravenous vancomycin 
must be used. In order to avoid the spread of drug-resistant bacteria to 
other patients, health care workers often wear sterile gowns and gloves 
when caring for people known to have these infections (Bergen and 
Shelhamer,1996; Fergie et al., 1994).  
1.13.2 Fungal infections  
Oral antifungal antibiotics like nystatin are used for people with 
fungal infections in the mouth and throat. Depending on the medication, 
the patient swishes and swallows the solution or lets the medication 
dissolve in their mouth. For more serious candida infections, medications 
such as Amphotericin B may be given intravenously. Amphotericin B is 
most often used to treat Aspergillus infection. Cryptococcus infection is 
usually treated with Amphotericin B, Flucytosine, or Fluconazole 
(Viscoliet al., 1997) 
1.13.3 Viral infections  
While antibacterial antibiotics have been available for over a half 
century, antiviral drugs were not developed until much more recently. 
Herpes simplex virus and varicella-zoster are usually treated with 
acyclovir, an antiviral agent. Gancyclovir is more commonly prescribed 
for Cytomegalovirus (CMV) (Zaia.1990).  
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1.13.4 Protozoal Infections  
Protozoa generally cause few problems for healthy individuals, but 
they are hard to treat in individuals with low WBC counts. The usual 
treatment for people with Pneumocystis carinii infection is 
Trimethoprim-Sulfamethoxazole. If people have side effects from these 
drugs, then Atovaquone or Pentamide may be used. Toxoplasma is often 
treated with Pyrimethamine plus Sulfadiazine or, Clindamycin for 
individuals are allergic to Sulfadiazine (Rubin and Ferraro1993). 
1.14 Infections of cancer patients in Sudan 
In the Sudan few studies addressed the problem of infection in 
patients with cancer. One of these studies was done by Abdalla (2000) 
who reported the isolation of bacteria and fungi from sputum, urine, 
infected wound, blood and skin scraping of  immunocompromised 
patients in Radiation and Isotope Center Khartoum, during the period 
from December 1997 to December 1998.He found that out of the 263 
clinical isolates, 88(59%) were isolated from sputum specimens, 
31(35.5%) were Klebsiella pneumoniae, 21(23.9%) were Streptococcus 
pneumoniae, 10 (11.4%) were Candida albicans, 9 (10.2%) were 
Psuedomonas aeruginosa, 7 (8%) were Mycobacterium tuberculosis, 6 
(6.8%) were Aspergillus fumigatus, and 4(4.5%) were Proteus mirabilis. 
He also recovered 86 isolates from urine specimens, 33 (38.3%) 
were Escherichia coli, 21(24.4%) were Enterococcus faecalis, 18(20.9%) 
were Candida albicans, 9 (10.5%) were Klebsiella pneumoniae, 3 (3.5%) 
were Psuedomonas aeruginosa, and2 (2.3%) were Proteus mirabilis. 
The total number of isolates he recovered from wound infections 
was 43, 24(55.8%) were Staph.aureus, 10(23%) were Proteus 
mirabilis,5(11.6%) were Psuedomonas aeruginosa, 3 (7.0%) were 
Escherichia coli, and 1 (2.3%) was Klebsiella pneumoniae.       
 29
The total number of isolates he recovered from blood specimens was 
39, 15 (38.5%) were Staph.aureus, 9 (23.1%) were Psuedomonas 
aeruginosa, 7 (17.9%) were Klebsiella pneumoniae and 8 (20.5%) were 
Streptococcus pneumoniae. 
Seven isolates (5%) were recovered from skin scrapings from 
patients with dermatomycosis. Malassezia furfur was the only isolate. 
Another study about the bacterial nosocomial infection in patients 
with different tumors hospitalized in Radiation and Isotopes Centre 
Khartoum by Rehan (2005) reported that the isolation of bacteria from 
118 (71.5%) urine samples, 14 (8.4%) surgical wound swabs, 9 (5.4%) 
ear swabs, 10 (6.0%) throat swabs and 14 (8.4%) samples collected from 
other sites of infection. 
A total of hundred organisms were isolated and identified, 9 (9%)  
Staphylococci aureus, 30 (30%) coagulase-negative Staphylocoooi, 25 
(25%) E. coli, 7 (7%) Klebsiella pneumoiae, 7 (7%) Proteus mirabilis, 6 
(6%) Peudomonas aeruginosa, 2 (2%) Enterobacter spp., 7 (7%) 
Candida albican. 3 (3%) Enterococci spp., 3 (3%) Streptococcus 
pyogenes, and 1 (1%) Salmonella  paratyphi B.  
Antimicrobial susceptibility revealed that Gentamicin and 
Streptomycin were found to be the most effective antimicrobial agent.  
All E.coli strains were found to be 100% susceptibile to Gentamicin and 
Streptomycin. Most coagulase-negative Staphylococci strains showed 
100% susceptibility to Gentamicin and 70-90 % susceptibility to 
Streptomycin, Ampicllin, Coloxacillin and Penicillin. 
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Chapter two 
Material and Methods 
2.1 STERILIZATION 
2.1.1 Sterilization of equipments 
Petri dishes, test tubes, forceps, flasks, Pasteur and graduated 
pipettes were sterilized in a hot air oven at 160 ˚C for one hour or 180 ˚C 
for half an hour.  
Bottles and plastic containers were sterilized by autoclaving at 121 
˚C (15 Ib/inch 2) for 15 minutes. 
2.1.2 Sterilization of culture media and solutions  
Media and solution were sterilized by autoclaving at 121 ˚C (15 
Ib/inch 2) for 15 minutes. 
2.2 REAGENTS 
2.2.1 Hydrogen peroxide 
This was prepared in a concentration of 3% aqueous solution and it 
was used for catalase test and obtained from Agropharm Ltd., 
Buckingham. 
2.2.2 Tetra methyl – p- phenylenediamine dihydrochloride  
This reagent was used for oxidase test; it was prepared as 1% 
aqueous solution. 
2.2.3 Alpha - naphthol solution 
Alpha-naplthol was obtained from BDH Ltd. This reagent was 
prepared as 5% aqueous solution for Voges – Proskaűer (VP) test.  
2.2.4 Potassium hydroxide  
It was used for Voges – Proskaűer (VP) test and was prepared 
according to Barrow and Feltham (1993) as 40% aqueous solution. 
 
 31
2.2.5 Methyl red  
It was prepared by dissolving methyl red (0.04g) in ethanol (40 ml). 
The volume was completed to 100 ml with distilled water. It was used for 
methyl red test. 
2.2.6 Nitrate test reagent  
Nitrate test reagent was consisting of two solution and they were 
prepared according to Barrow and Feltham (1993). Solution A was 
consisting of 0.33 % sulphanilic acid. Solution B was consisting of 0.6% 
diethyl-α – naphthylamine, both dissolved by gentle heating in 5N- acetic 
acid. 
2.2.7 Kovac's reagent  
This reagent consisted of 5g P-dimethylaminobenzaldeyde, 75 ml 
amyl alcohol and 25 ml concentrated hydrochloric acid. It was prepared 
according to Barrow and Feltham (1993) by dissolving the aldehyde in 
the alcohol by heating in water bath. Then it was cooled and the acid was 
added. The reagent was used for indole test and was stored at 4˚C. 
2.3 INDICATORS 
2.3.1 Andrade's indicator  
This was prepared according to Barrow and Feltham (1993)by 
dissolving 5g of acid fuchsin in one liter of distilled water and 150 ml 
alkali solution was added. The solution was mixed and allowed to stand 
at room temperature for 24h with frequent shaking until the color became 
brown. This was used for sugar fermentation test. 
2.3.2 Phenol red  
Phenol red was obtained from Hopkins and William Ltd. It was used 
for urea agar base medium. It was prepared as 0.2% solution.  
2.3.3 Neutral red  
Neutral red was used for adjusting the pH. It was product of Hopkins 
and William Ltd .London. 
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2.3.4 Bromothymol blue  
This solution was prepared by dissolving 0.2g of the bromothymol 
blue powder (BDH Ltd.) in 100 ml distilled water .It was used for 
Oxidation fermentation test. 
2.4 BLOOD  
It was collected from jugular vein of healthy sheep in sterile flask 
containing glass beads and was mixed gently. The blood was distributed 
in 10ml amount in sterile screw capped bottles and stored in refrigerator. 
Defibrinated sheep blood was used in preparing blood agar medium.   
2.5 MEDIA  
Different types of media including solid, semisolid, and liquid media 
were used for isolation and identification of bacteria. 
2.5.1 Solid media  
2.5.1.1 Nutrient agar medium  
This medium was obtained from Oxoid Ltd. It consists of yeast 
extract, sodium chloride, peptone and agar (2%). It was prepared 
according to manufacturer's instructions by dissolving 28 g of the powder 
in 1 liter of distilled water by boiling. The pH was adjusted to 7.4 and the 
medium was sterilized by autoclaving at 121˚C for 15 minutes, cooled to 
50-55 ˚C. The medium was distributed into sterile Petri dishes in 20 ml 
amount and allowed to solidify on leveled surface.  
2.5.1.2 Blood Agar medium  
This medium was composed of dehydrated blood agar base obtained 
from Oxoid and defibrinated sheep blood. The blood agar base contained 
heart infusion, tryptose, sodium chloride and agar. It was prepared 
according to manufacture's instruction by dissolving 40 g in 1 liter of 
distilled water by boiling, mixed and sterilized by autoclaving at 121˚C 
for 15 minutes, and cooled to 50˚C. Defibrinated sheep blood was added 
aseptically to give final concentration 10%, mixed gently and 15ml of 
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complete medium was poured into sterile Petri dishes. The poured plates 
were allowed to solidify at room temperature on flat surface.   
2.5.1.3 Urea agar medium  
It consisted of peptone, dextrose, sodium chloride disodium 
phosphate, phenol red and agar. An amount of 2.4 g of powder were 
suspended in 95 ml of distilled water and steamed to dissolve completely. 
The pH was adjusted to 6.8, sterilized by autoclaving at 115 ˚C (10 Ib 
/inch 2) for 20 minutes and then cooled to 50 ˚C. Five ml of sterile 40% 
urea solution (Oxoid Ltd) were added aseptically, mixed well and 
distributed as 5ml amounts into sterile bottles. The bottles were allowed 
to set in aslope position. 
2.5.1.4 Simon's citrate medium  
This medium was supplied by Oxoid (Ltd.). It was the modified 
Koser's citrate medium. It consisted of NaCl, MgSO4.7H2O, NH4H2PO4, 
K2HP04, citric acid, distilled water, bromothymol blue and agar. Twenty-
three grams of the medium were dissolved by steaming in one liter of 
distilled water. The pH was adjusted to 7.0 and sterilized by autoclaving 
at 115 ˚C for 15 minutes. The medium was then distributed into sterile 
McCartney bottles and allowed to set in a slope position. 
2.5.1.5 Mueller Hinton medium  
This medium was supplied by Scharlau (Ltd.). It consisted of 
peptone, beef infusion solid, starch, and agar. 
The medium (38 g) was dissolved completely by boiling in one liter 
of distilled water and the pH was adjusted to 7.3. The medium was 
sterilized by autoclaving at 121˚C for 15 minutes and cooled to 45-50˚C. 
The medium was then distributed into sterile Petri dishes in about 20 ml 
amounts and allowed to solidify at room temperature on leveled surface.    
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2. 5.2 Semi – solid media  
2.5.2.1 Hugh and Leifson's (O-F) medium  
This medium was prepared as described by Barrow and Feltham 
(1993). It consisted of potassium hydrogen phosphate (0.3g), sodium 
chloride (5g), peptone (2g) and agar (3g). The solid powders were 
dissolved by heating in one liter of distilled water. The pH was adjusted 
to 7.1, filtered and 15 ml of aqueous solution of 0.2% concentration of 
bromothymol blue indicator were added, and then sterilized at 115˚C for 
20 minutes. A sterile solution of glucose or appropriate carbohydrate was 
added to give a final concentration of 1%. The complete medium was 
distributed into 10 ml volumes into sterile test tubes.  
2.5.2.2 Motility medium  
 This medium was supplied by Oxoid (Ltd.) It consisted of 13g of 
nutrient broth, 1 liter of distilled water and 5 g of Oxoid agar No 1. The 
solid powder was suspended in a liter of distilled water , steamed to 
dissolve , distributed in 5-6ml amounts in test tubes containing Craigie  
tubes and autoclaved at 121˚C for 15 minutes . Then the medium was 
allowed to cool. 
2.5.3 Liquid media  
2.5.3.1 Nutrient broth  
This medium was supplied by Oxoid (Ltd.) It consisted of peptone, 
yeast extract and sodium chloride. It was prepared according to Barrow 
and Feltham (1993) by dissolving 13 g of medium in 1 liter of distilled 
water and the pH was adjusted to 7.4. The medium was distributed into 
screw capped bottles 5ml each and sterilized by autoclaving at 121˚C for 
15 minutes.  
2.5.3.2 Peptone water  
It was prepared as described by Barrow and Feltham (1993). Ten 
grams of peptone powder (Oxiod Ltd.) and 5g of sodium chloride were 
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dissolved in one liter of distilled water. The pH of the medium was 
adjusted to 7.2-7.4, and distributed into screw capped bottles and 
sterilized by autoclaving at 121˚C for 15 minutes.  
2.5.3.3 Peptone water sugar  
It was prepared as described by Barrow and Feltham (1993). Nine 
hundred ml of peptone water were prepared and the pH was adjusted to 
7.1-7.3. Ten ml of Andrade's indicator were added. Sugar solution was 
prepared by dissolving 10g of appropriates sugar in 90 ml of distilled 
water. This sugar solution was added to the peptone water, distributed in 
5ml volume into sterile test tubes with inverted Durham's tube and 
sterilized by autoclaving at 121˚C for 15 minutes.  
The carbohydrates tested were glucose, mannitol, sucrose, lactose 
fructose, maltose, xylose, raffinose, salicin, adenitol and dulictol. 
2.5.3.4 Nitrate broth  
This medium contains one gram of potassium nitrate. It was 
prepared according to Barrow and Feltham (1993) by dissolving the 
nitrate in one liter of nutrient broth, distributed in 5ml amounts into test 
tubes and sterilized by autoclaving at 115˚C for 20 minutes. 
 2.5.3.5 Glucose –phosphate medium (MR-VP test medium) 
This medium was prepared according to Barrow and Feltham (1993). 
Five grams of peptone and 5 g of phosphate buffer (K2HPO 4) were added 
to one liter of distilled water, dissolved by steaming, filtered and pH was 
adjusted to 7.5. Then 5g of glucose were added, mixed well, distributed 
into test tubes and sterilized by autoclaving at 115˚C for 20 minutes. 
2.6 Sample collection  
Fifty swab samples were collected during February-August 2006 in 
Radiation and Isotopes Center- Khartoum from infected cancer wounds. 
The samples were labeled and placed on ice in thermos flasks and 
transported immediately to the laboratory of the Department of 
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Microbiology, Faculty of Veterinary Medicine, University of Khartoum. 
The samples were collected from 21(42%) adult females, 16 (32%) adult 
male and 13(26%) children. All samples were cultured onto blood agar 
within two hours of collection.  
2.7 Cultural methods  
The swabs were inoculated onto 10% defibrinated sheep blood agar. 
The inoculated plates were incubated aerobically at 37 ˚C for 24 h. 
Further incubation was continued for another 24 hours and if no growth 
was evident, then the plates were discarded as negative. 
2.7.1 Examination of cultures  
All cultures on solid media were examined with naked eye for 
growth and colonial morphology and any changes in medium. The liquid 
media were also examined with naked eye for turbidity, color change, 
formation of sediment and accumulation of gas in the Durham's tube in 
case of carbohydrates media. 
2.7.2 Purification of cultures  
All bacteria isolated were purified by several sub-culturing from 
single well separated colony on either blood agar or nutrient agar 
medium. The purity of culture was checked by staining with Gram's stain, 
and then stored at 4 ˚C.  
2.7.3 Preservation of cultures  
Each of purified isolates was inoculated into Bijou bottle containing 
slope of nutrient agar medium, allowed to grow and then stored at 4 ˚C. 
The preserved cultures were sub-cultured every three months. 
2.8 Identification of isolated bacteria 
2.8.1 Primary identification  
2.8.1.1 Preparation of smears  
Small inoculum's of bacterium colony was emulsified in a drop of 
sterile normal saline and spread on a clean slide. Smears from liquid 
 37
media were prepared by spreading a loopful on slide. Smears were 
allowed to dry in air and then fixed by gentle heating.  
2.8.1.2 Gram's staining method 
This was done as described by Barrow and Feltham (1993). The 
stained smears were examined microscopically to see the shape, 
arrangement, and staining reaction of the bacterium. 
2.8.1.3 Catalase test  
The test was carried out as described by Barrow and Feltham (1993). 
A drop of 3% aqueous solution of hydrogen peroxide was placed on a 
clean slide. Small amount of the tested organism colony was added to the 
drop and mixed by a wood stick. Production of air bubble indicated 
positive result. 
2.8.1.4 Oxidase test 
The test was carried out as described by Barrow and Feltham (1993). 
The tested organism was grown on nutrient agar. Strips of filter paper 
soaked in 1% solution of tetra methyl-p-phenylenediamine 
dihydrochloride and dried at 50 ˚C were placed on a clean slide. The 
tested organism was picked with a sterile clean bent glass rod and rubbed 
on the filter paper. A dark purple color that developed after 5-10 seconds 
indicated positive result. 
2.8.1.5 Motility test 
The semi-solid motility medium containing Craigie tube prepared as 
described before was used to detect motility. A small piece of a colony of 
the tested organism was picked by the end of straight wire and stabbed in 
the centre of semi solid agar in the Craigie tubes, then incubated at 37 ˚C. 
If the growth of organism was detected outside and inside the Craigie 
tubes the organism was considered motile. 
2.8.1.6 Oxidation fermentation (O-F) test 
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The test was carried out as described by Barrow and Feltham (1993). 
Two tubes of Hugh and Leifson's medium were inoculated with tested 
organism. One was being covered with a layer of sterile melted soft 
paraffin oil to a depth of 1-2 cm. to seal from air. They were then 
incubated at 37 ˚C and examined daily for up to fourteen days. Yellow 
color in open tube only indicated oxidation of glucose, yellow color in 
both tubes showed fermentation reaction and blue or green color in open 
tube and green color in sealed tube indicated production of alkali.   
2.8.2 Secondary identification of bacteria    
This was done as described by Barrow and Feltham (1993). 
2.8.2.1 Sugar fermentation test  
The peptone water sugar medium was inoculated with the tested 
bacterial isolate, incubated at 37 ˚C and then examined daily for seven 
days. Acid production was indicated by appearance of reddish color, 
while gas production was indicated by the presence of an empty space in 
the inverted Durham's tubes. 
2.8.2.2 Urease test  
A slope of urea agar medium was inoculated with tested organism 
and incubated at 37 ˚C for two days. An appearance of pink color 
indicated positive result. 
2.8.2.3 Citrate utilization test 
Simmon's citrate medium was inoculated with the tested organism 
and incubated at 37 ˚C. Then examined daily for seven days. Growth of 
the organism and changed color to blue indicated positive result.  
2.8.2.4 Coagulase test  
2.8.2.4.1 Slide coagulase test  
Two colonies of tested culture were placed on a clean glass slide, 
emulsified in a drop of normal saline, a loopful of human plasma was 
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added to the drop of bacterial suspension and mixed. Appearance of 
coarse microscopically visible clump was recorded as positive result. 
2.8.2.4.2 Tube coagulase test  
To 0.5ml of 1:10 dilution of human plasma in normal saline, 0.1 ml 
of an 18-24 hours old broth culture of tested organism was added, then 
incubated in water bath at 37 ˚C and examined after 4-6 hours for 
coagulation. Definite clot formation indicated positive result. 
2.8.2.5 Indole production test 
 Peptone water was inoculated with tested organism and incubated at 
37 ˚C for 24-48 hours. Then 0.5 ml of Kovc's reagent was added.  
Production of red color on the upper layer of the reagent indicated 
positive result.   
2.8.2.6 H2S production test 
A tube of peptone water was inoculated with tested organism and 
lead acetate paper was inserted between the cotton plug and the tube. The 
tubes were incubated at 37 ˚C and examined daily for seven days for 
blackening of paper due to H2S production. 
2.8.2.7 Nitrate reduction test 
The test was carried out as described by Barrow and Feltham 
(1993).Nitrate broth was inoculated with the tested organism and 
incubated at 37 ˚C for two days. Then 1 ml of nitrate reagents A was 
added followed by 1 ml of reagent B. Red color indicated positive 
reaction that showed nitrate in the medium had been reduced. If red color 
did not develop, powdered zinc was added to see whether there was 
residual nitrate or not. Red color development indicated that nitrate in 
medium had been reduced to nitrate by zinc but not by the organism, 
whereas unchanged color indicated nitrate in original medium had been 
reduced completely and nitrite was further broken down by the organism. 
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2.8.2.8 Voges- Proskaur ( VP ) test 
This test was carried out as described by Barrow and Feltham 
(1993). This test was used to detect production of acetyl methyl carbonyl. 
Glucose phosphate medium was inoculated with tested organism and 
incubated at 37 ˚C for 48 hours. Then 0.6 ml of 5% α –naphthol followed 
by 0.2 ml of 40% potassium hydroxide aqueous solution were added to 
one ml of the culture, shaken well and examined after 15 minutes and one 
hour. A positive reaction was indicated by appearance bright pink color.      
2.8.2.9 Methyl red test  
Glucose phosphate medium was inoculated with the tested organism 
and incubated at 37 ˚C for 48 hours. Then 5-6 drops of methyl red 
solution were added and the tube was shaken. Red color appearance 
indicated positive reaction. 
2.9 Sensitivity to antibiotics  
2.9.1 Sensitivity test method  
The antibiotics sensitivity of bacterial strains isolated in this study 
were tested by diffusion technique (Cruickshank et al., 1975). The tested 
bacterium was grown in peptone water and incubated at 37 ˚C for two 
hours. The Petri dishes containing Mueller Hinton medium was dried in 
oven at 40 ˚C for 20 minutes, then 1-2 ml of the culture was poured on it 
and the inoculum was distributed and a pipette was used to withdraw off 
the excess fluid. The plate was left to dry at room temperature for 15 
minutes. Commercial discs obtained from Oxoid (Ltd.) were placed on 
the surface of the inoculated Mueller Hinton agar medium using sterile 
forceps. Then incubated aerobically at 37 ˚C for 16-18 hours. After 
incubation, the plates were examined for growth inhibition around discs 
and the diameter zone of growth inhibition was measured in millimeters. 
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Chapter three 
3. RESULTS 
3.1 Survey 
  
Fifty samples were collected randomly from cancer patients with 
wound infection and abscesses in Radiation and Isotopes Center. The 
samples were collected from 21 adult females, 16 adult male and 13 
children. 
3.2 Bacterial isolation  
All samples were cultured onto blood agar medium and incubated 
aerobically at 37 oC. Forty seven samples revealed growth of bacteria, 
while three samples did not revealed any growth. 
3.3 Characterization and identification of isolates  
The bacterial isolates obtained in this study were identified 
according to their cell morphology, Gram stain reaction, cultural 
characteristics, and their biochemical properties as described by Barrow 
and Feltham (1993). 
The total number of bacterial isolates was sixty four; 26 were Gram 
positive isolates and 38 were Gram negative isolates. 
3.4 Gram positive bacteria 
The total number of Gram-positive bacteria was 26 (40.6%) 
isolates. They were further characterized as Staphylococcus spp and 
Sterptococcus spp.  
3.4.1 Staphylococcus spp 
Twenty three isolates of Staphylococcus spp were isolated in this 
study. They were 20 (31.2%) Staphylococcus aureus, 2 (3.1%) 
Staphylococcus epidermidis and 1 (1.6%) Staphylococcus saprophyticus 
(Table 3). These isolates were Gram-positive bacteria, non motile, non 
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spore forming and fermented a number of sugars. When Staphylococcus 
aureus was cultured on blood agar and incubated at 37 oC for 24 hours, 
a wide zone of beta hemolysis was produced around the colonies as 
shown in Table 1. 
3.4.2   Streptococcus spp 
The Streptococcus spp isolated in this study were identified 
according to their morphology and Gram-stain reaction and they were 
also identified on the basis of their biochemical properties. They were 
Gram-positive cocci, arranged in chains, non-motile, non-spore 
forming. They were 3 (4.7 %) of the total Gram-positive bacterial 
isolation. 
3.5 Gram-negative bacteria 
Thirty eight (59.4%) isolate of Gram-negative bacteria were 
isolated in this study. They consisted of Pseudomonas spp17 (26.6%), 
Proteus spp5 (7.8%), Escherichia coli 9(14.1%), and Klebsiella spp7 
(10.9%) as shown in Table 3 and Fig. 5. 
3.5.1 Pseudomonas 
The seventeen (26.6%) strains of Pseudomonas spp isolated in this 
study were Pseudomonas aeruginosa. They represent the highest 
percentage of the total Gram-negative isolates. These isolates were 
Gram-negative rods; oxidase positive, motile, catalase positive and they 
produced pigment on nutrient agar (Table 2, Fig. 4). 
3.5.2 Escherichia coli  
Nine (14.1%) strains of Escherichia coli were identified. They 
were Gram-negative rods, motile, catalase positive, indole positive, 
produced acid and gas from glucose, lactose, maltose, mannitol, and 
xylose (Table 2). 
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3.5.2 Klebsiella spp  
The seven (10.9%) strains of Klebsiella spp isolated in this study 
were Klebsiella pneumoniae. They were Gram-negative straight rods, 
arranged singly, in pairs or short chains and they were slightly thicker 
and shorter than other enterobacteria.They were catalase positive, non-
motile, oxidase negative and fermented sugars (Table 2). 
3.5.3 Proteus spp 
 The five (7.8%) strains of Proteus spp. isolated in this study were 
Proteus mirabilis. They were Gram-negative rods, motile, catalase 
positive, oxidase negative and fermented sugars (Table2). 
3.6 Antibiotic sensitivity test 
The bacteria isolates of this study were subjected to antimicrobial 
susceptibility testing by disc diffusion method on Mueller Hinton 
medium using commercial antibiotics discs. 
3.6.1 Sensitivity of Staphylococcus spp. to antibiotics  
The Staphylococcus aureus isolated in this study showed high 
resistance to Penicillin (100%), Ampicillin (100%), and Tetracycline 
(90%) as shown in Table 8 and 4 (20%) isolates showed very high 
resistance to the eight antimicrobial as shown in Table 10, and Fig 1 
3.6.2   Sensitivity of Streptococcus spp to antibiotics 
The streptococcus isolates in this study were sensitive to 
Gentamicin (100%) and Streptomycin (100%) and showed variable 
sensitivity to other antibiotics as illustrated in Table 6. 
3.6.3 Sensitivity of Pseudomonas spp to antibiotics 
The 13 (76.47%)  Pseudomonas isolates in this study revealed very 
high resistance to the 8 antimicrobial agents and only one isolate 
showed resistance to 6 antimicrobial agents as shown in Table 11 and 
Fig 2 the resistance varied from 94-100% (Table 9), however, they 
showed low sensitivity to Gentamiycin 23.5% as shown in Table 7. 
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3.6.4 Sensitivity of Escherichia coli to antibiotics 
The sensitivity of Escherichia coli isolates in this study to 
Gentamycin, Streptomycin, Nalidixic acid, Nitrofurantion and 
Tetracycline varied between 76.6% -100%  (Table 7) and showed 
resistance to Cotrimoxazol (77, 8%) and Ampicillin (77, 8%)  as shown 
in Table 9 and Fig 3. 
3.6.5 Sensitivity of Klebsiella spp to antibiotics 
Klebsiella spp isolates in this study were sensitive Gentamycin 
(85.7%) and Streptomycin (71.4%) and showed variable sensitivity to 
other antibiotics as shown in Table 7. 
3.6.6 Sensitivity of Proteus spp to antibiotics 
The Proteus spp strains isolated in this study were highly 
sensitivite to Gentamycin (100%) and Sterptomycin (80%) and showed 
variable sensitivity to other antibiotics as illustrated in Table 7. 
Antibiotics sensitivity and resistance of Gram-positive and Gram-
negative isolates are summarized in Fig 4 and 5. 
Gentamicin was found to be the most potent antibiotics against 
Gram-positive (84. 6%)   and Gram-negative (63. 2%) isolates followed 
by Streptomycin which was potent against (65. 4%) of Gram-positive 
and (44. 7%) of Gram-negative isolates.     
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Table (1) Characters and biochemical properties of Gram-positive 
bacteria isolated from infected wound samples collected 
from cancer patients in Radiation and Isotopes Center.  
 
Staphylococcus 
saprophyticus 
Staphylococcus 
epidermidis 
Staphylococcus   
aureus 
Character 
S S S Shape 
+ + + Gram reaction 
- - - Spore forming 
+ + + Aerobic growth 
- - - Motility 
+ + + Catalase 
- - - Oxidase 
F F F O/F 
- - + Coagulase 
- + + Phosphatase 
+ + + VP 
- + + Nitrate reduction 
   Sugar fermentation 
A.p. from: 
+ + + Glucose 
+ + + Sucrose 
+ - + Mannitol 
+ + + Lactose 
+ + + Fructose 
+ - + Trehalose 
- + + Mannose 
+ + + Maltose 
- - - Xylose 
- - - Raffinose 
A.p: acid production  :+ و   Positive, - : Negative, F: Fermentative, O: Oxidative. 
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Table (2) Characters and biochemical properties of Gram-negative 
bacteria isolated from infected wound samples collected 
from cancer patients in Radiation and Isotopes Centre. 
 
Pseudomonas 
aeruginosa 
Klebsiella 
pneumoniae 
Proteus 
mirabilis 
Escherichia 
coli 
Character 
Rod Rod Rod Rod Shape 
+ - + + Motility 
+ - - + Oxidase 
+ + + + Catalase 
+ - + + citrate 
+ + + - Urease 
- - - + Indole 
- - + - H2s production 
- - + + MR 
- + - - VP 
    Sugar fermentation 
A.p. from: 
+ + + + Glucose 
- V - + Maltose 
- V - + Lactose 
+ + - + Mannitol  
- + - V Raffinose  
- + - V Salicin 
- + + V Sucrose 
+ + + + Trehalose 
+ + + + Xylose 
V V V V Adenitol 
V V + V Dulictol 
- + - +  Rhamnose 
 :+ Positive, -: Negative, F: fermentative, O: oxidative, V: variable. A.p: acid 
production 
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Table (3) Bacteria species isolated from infected wound samples 
collected from cancer patient in Radiation and Isotopes 
Centre. 
 
Bacteria species ٭Number isolated 
(Percentage) 
٭٭ Isolation rate 
(Percentage) 
Staphylococcu arueus 20 (31.2 %) 20 (40 %) 
Staphylococcus epidermidis 2 (3.1 %) 2 (4 %) 
Staphylococcus saprophyticus 1 (1.6 %) 1 (2 %) 
Streptococcus spp 3 (4.7 %) 3 (6 %) 
Pseudomonas aeruginosa 17 (26.6%) 17 (34%) 
Escherichia coli 9 (14.1 %) 9 (18 %) 
Klebsiella pneumoniae 7 (10.9 %) 7 (14 %) 
Proteus mirabilis 5 (7.8 %) 5 (10 %) 
Total number of isolates 64 (100 %) 64 (128 %) 
٭Calculated from the total number of isolates. 
٭٭Calculated from the total number of samples examined. 
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Table (4) Gram-negative bacteria isolated from infected wound sample 
collected from cancer patients in Radiation and Isotopes 
Center.  
 
٭٭ Isolation rate           
(Percentage) 
٭Number isolated 
(Percentage) 
Bacteria species  
17 (34%) 17 (26.6%) Pesdomonas aeruginosa 
9 (18 %) 9 (14.1 %) Escherichia coli 
7 (14 %) 7 (10.9 %) Klebsiella pneumoniae 
5 (10 %) 5 (7.8 %) Proteus mirabilis 
38 (76 %) 38 (100 %) Total number of isolates 
٭Calculated from the total number of isolates. 
٭٭Calculated from the total number of samples examined. 
 
 
 
 
Table (5) Gram-positive bacteria isolated from infected wound samples 
collected from cancer patients in Radiation and Isotopes 
Centre. 
 
٭Number isolated 
(Percentage) 
٭٭ Isolation rate 
(Percentage) 
Bacteria species  
20 (31.2 %) 20 (40 %) Staphylococcu arueus 
2 (3.1 %) 2 (4 %) Staphylococcus epidermidis 
1 (1.6 %) 1 (2 %) Staphylococcus saprophyticus 
3 (4.7 %) 3 (6 %) Streptococcus spp  
26 (52 %) 26 (100 %) Total number of isolates 
٭Calculated from the total number of isolates. 
٭٭Calculated from the total number of samples examined. 
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Fig. 1 Staphylococcus aureus isolated from infected cancer wound 
showed multi-drug resistance to Ampicillin, Chloroampencol, 
Cloxcillin, Erthromycin, Gentamycin, Pencillin, Streptomycin 
and Tetracycyline. 
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Fig. 2  Pseudomonas spp. isolated from infected cancer wound 
showed multi drug resistance to Ampicillin, Cotrimoxazole, , 
Nalidixic acid, Nitrofurantion, Colistin, and Tetracycyline. 
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Fig. (3) Antibiotic sensitivity of E. coli isolate from infected wound 
sample collected from cancers patient in Radiation and 
Isotopes Centre. 
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Fig 4: Antibiotic sensitivity of Gram-positive bacteria isolated from 
infected wound samples collected from cancer patients in 
Radiation and Isotope Centre 
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Fig. (5) Antibiotic sensitivity of Gram-negative bacteria isolated from 
infected wound samples collected from cancer patients in 
Radiation and Isotope Centre 
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Chapter Four 
4. Discussion 
Fifty samples were collected randomly from cancer patients with 
wound infection and abscesses in Radiation and Isotopes Center. The 
samples were collected from 21 adult females, 16 adult male and 13 
children. All samples were cultured onto blood agar medium and 
incubated aerobically at 37 oC. Forty seven (94%) samples revealed 
growth of bacteria, while three samples (6%) did not give any growth. 
The results revealed that 94% of cancer wound infections were infected 
by aerobic bacteria, while the remaining 6% cases may be infected with 
other organisms which may be anaerobic bacteria, viruses or fungi.  
The bacteria isolated from different patients in this study were 
Pseudomonas spp 17 (45%), Proteus spp 5 (13.2%), Escherichia coli 
9(23.7%), Klebsiella spp 7 (21.5%), Staphylococcus aureus 20(31.2%), 
Staphylococcus epidermidis 2 (3.1%), Staphylococcus saprophyticus 
1(1.6%) and Streptococcus spp 3 (4.7%). 
The most common bacteria isolated were Staphylococcus aureus 
which accounted for 31.2% of the isolation in this study and this agrees 
with Rehan (2005) who found that 43% of nosocomial isolates in the 
surgical – sites infections were Staphylococcus aureus. Also this result is 
in agreement with Abdalla (2000) who reported that in the case of wound 
infections, the number of Staph. arueus isolates was 24(55.8%). Beck et 
al. (1994) reported that staphylococci have replaced E coli as the 
predominant pathogen in primary blood stream infections. The major 
causes of surgical site infections are S aureus, coagulase- negative 
staphylococci, and enterococci.  Also, this result confirmed the data from 
the National Nosocomial Infections Surveillance System for the Centers 
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for Disease Control and Prevention (CDC) which showed that S aureus 
was the most common cause of nosocomial pneumonia and surgical 
wound infections and the second most common cause of nosocomial 
blood stream infections. Staphylococci are present in the upper 
respiratory and upper epithelial surface and the skin (Hirsh et al., 2004). 
Because staphylococcus is one of major skin flora wound infection, often 
arise endogenously. Most infections in patient with cancer were caused 
by organisms that normally colonize areas adjacent to the site of infection 
such as Staphylococcus aureus, this indicates that, most organisms caused 
infection were opportunistic i.e. cause infection when there is defect in 
the host, immune response Although these organisms may be considered 
as part of the normal flora they often acquired nosocomially. In this study 
infection cause by  Staphylococcus aureus was most common this is due 
to the wide present of the bacteria in the human body as normal flora and 
in the environment especially hospital environment.  
The second bacterial isolate caused wound infection in this study 
was Pseudomonas aeruginosa 17(44.7%) and this result is in agreement 
with Wibin (1997); Pollak (1995); Gorden et al. (1998); and Kluytman 
(1997) who reported that Pseudomonas aeruginosa, an increasingly 
prevalent opportunistic human pathogen, is the most common Gram-
negative bacterium found in nosocomial infections. P. aeruginosa is 
responsible for 16% of nosocomial pneumonia cases, 12% of hospital-
acquired urinary tract infections, 8% of surgical wound infections and 
10% of bloodstream infections. Also this result confirmed the finding of 
Kennth (2004) who reported that, Pseudomonas aeruginosa is a serious 
problem in patients hospitalized with cancer, cystic fibrosis, and burns 
and the case rate in these patients is 50 percent. Pseudomonas aeruginosa 
is a frequent cause of bacteremia in human beings with burns, leukemia 
or cystic fibrosis (Hirsh et al., 2004).    
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The most common infections in cancer patients in this study were 
caused by Gram negative bacteria rods especially enterobacteriaceae 
organisms which include Escherichia coli, Proteus spp, and Klebsiella 
spp. This indicates the source of infection may be endogenous especially 
from the intestinal tract. This result is in agreement with Beck et al. 
(1994) who reported that Coliform and Proteus bacilli currently cause 29 
percent of nosocomial (hospital-acquired) infections in the United States. 
In order of decreasing frequency, the major sites of nosocomial infection 
are the urinary tract, surgical sites, blood stream, and pneumonias. These 
groups of nosocomial pathogens are responsible for 46% of urinary tract 
and 24% of surgical site infections, 17% of the bacteremias, and 30% of 
the pneumonias. E coli is the premier nosocomial pathogen. Elisabeth et 
al .,(2004) reported that, pathogenic E coli acquired in hospital infected 
wounds, urinary tract, peritoneum and lung.  
This result also confirmed the findings of Rehan (2005) who found 
that nosocomial isolates in the surgical – site infections including the 
following isolates: Staphylococcus aureus, 43%, Echerichia .coli,14.3 %, 
Klebsiella pneumoniae ,7.1%, Pseudomonas aeruginosa, 14.3%, and 
Proteus vulgaris ,14.3%. National Nosocomial Infections Surveillance 
(NNIS) System stated that among 6,290 pediatric Intensive Care Unit  
(ICU) patients surveyed between 1992-1997, the incidence of nosocomial 
invasive bacterial and fungal infections were as follows: Nosocomial 
etiologies in surgical-site infections include the following: S aureus, 20%, 
Pseudomonads, 16%, Coagulase-negative staphylococci, 15% and 
Enterococci, fungi, Enterobacter species, and Escherichia coli, less than 
10% each. Neutropenic cancer and bone marrow transplant patients are 
particularly susceptible to opportunistic infections, Klebsiellae have also 
been incriminated in nosocomial infections. Common sites include the 
urinary tract, lower respiratory tract, biliary tract, and surgical wound 
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sites (Kaye, 1998). Klebsiella species are found in the mucosa of upper 
respiratory tract, intestine and genitourinary tract of man (Chessburgh, 
2000). These sites are possible source of K. pneumoniae infected wound 
in this study. 
Antimicrobial susceptibility testing was carried out by disk 
diffusion method on Mueller Hinton agar medium by Kirby-bauer 
technique. The Staphylococcus aureus isolated in this study showed high 
resistance to Penicillin (100%), Ampicillin (100%), Tetracycline (90%) 
and few isolates 4 (20%) showed very high resistance to the eight 
antimicrobial which examined in this study and this result is in agreement 
with the results obtained by Rehan (2005). Also this finding agrees with 
Abdelhameed (1999) who found that Staphylococcus spp was resistant to 
Penicillin (97.9%), Ampicillin (92.9%), and Tetracycline (52%).  Neu 
(1992) reported that more than 95% of patients with S aureus infection 
worldwide do not respond to first-line antibiotic such as Penicillin and 
Ampicillin.  
Also these results confirmed the report of Tolan (1993) who 
reported that, less than 5% of S. aureus remained sensitive to Penicillin 
and Garrett (1997) who stated that Staphylococci were the most common 
causes of community- and hospital-acquired infection. In many U.S. 
hospitals, strains of Staphylococci (i.e., Staphylococcus aureus or 
coagulase-negative Staphylococci) were resistant to all available 
antimicrobials except Vancomycin 
Kennth (2004) reported that Staphylococcus aureus is one of the 
major resistant pathogens found on the mucous membranes and the skin 
of around a third of the population, it is extremely adaptable to antibiotic 
pressure. It was the first bacterium in which penicillin resistance was 
found in 1947, just four years after the drug started being mass-produced. 
Methicillin was then the antibiotic of choice. Methicillin-resistant 
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Staphylococcus aureus (MRSA) was first detected in Britain in 1961 and 
is now "quite common" in hospitals. MRSA was responsible for 37% of 
fatal cases of blood poisoning in the UK in 1999. Half of all S. aureus 
infections in the US are resistant to Penicillin, Methicillin, Tetracycline 
and Erythromycin. 
All isolates of Pseudomonas aeruginosa isolated in this study were 
resistant to Ampicillin (100%), Cotrimoxazole (100%), Nalidixic acid 
(100%), Nitrofurantion(100%), Colistin(100%), Tetracycline(100%), 
Streptomycin ( 94.3%) and  Gentamycin (76.5%). These results are in 
agreement with the result obtained by Rehan (2005) and Abdelhameed 
(1999). Kennth (2004) reported that Pseudomonas aeruginosa is naturally 
resistant to many antibiotics due to the permeability barrier afforded by 
its outer membrane lipopolysaccharide (LPS). Also, its tendency to 
colonize surfaces in a biofilm form makes the cells impervious to 
therapeutic concentrations of antibiotics. Since its natural habitat is the 
soil, living in association with the bacilli, actinomycetes and molds, it has 
developed resistance to a variety of their naturally-occuring antibiotics. 
Moreover, Pseudomonas maintains antibiotic resistance plasmids, both R-
factors and Resistance Transfer Factors (RTFs), and it is able to transfer 
these genes by means of the bacterial processes of transduction and 
conjugation. Only a few antibiotics are effective against Pseudomonas, 
including Fluoroquinolones, Gentamicin and Imipenem, and even these 
antibiotics are not effective against all strains. 
The sensitivity of E.coli isolates isolated in this study to 
Gentamicin, Streptomycin, Nalidixic acid, Nitrofurantion and 
Tetracycline varied between 76.6% - 100%, while they showed low 
sensitivity to Ampicillin and Cotrimoxazole (22.2%). This result is in 
agreement with that mentioned by Beck et al. (1994) who reported 
resistance of E coli to Ampicillin, and first generation Cephalosporins is 
 65
increasing rapidly to the extent that they can no longer be considered 
primary drugs of choice in empirical treatment of urinary tract infections. 
The sensitivity of K. pneumoniae isolates isolated in this study to 
Gentamicin and Streptomycin was 85.7% and 71.4% respectively. This 
result is in agreement with the result obtained by Rehan (2005). However, 
the resistance to other antibiotics examined in this study varied between 
72%-100% and this finding is in agreement with findings of Beck et al. 
(1994). Klebsiella infections are encountered far more often now than in 
the past. This is probably due to the bacterium's antibiotic resistance 
properties. Klebsiella species may contain resistance plasmids (R-
plasmids) which confer resistance to such antibiotics as Ampicillin and 
Carbenicillin. To make matters worse, the R-plasmids can be transferred 
to other enteric bacteria not necessarily of the same species. 
The Proteus spp isolated in this study were highly sensitivite to 
Gentamycin (100%) and Streptomycin (80%) and show variable 
sensitivity to other antibiotics and they show less sensitivity to Ampicillin 
(40%) and this result disagrees with Kaye (1998) who reported that most 
strains of Proteus mirabilis are sensitive to Ampicillin and 
Cephalosporins. P. mirabilis is generally susceptible to most antibiotics 
apart from Tetracycline, however 10%–20% of P. mirabilis strains are 
also resistant to first generation Cephalosporins and Ampicillins (Kaye 
,1998). 
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Conclusions 
From the results of this investigation, it can be concluded that: 
• This study revealed that bacterial infection of wounds of cancer 
patients is one of major problems which may contribute, together 
with malignancy to more serious complication. 
• The bacterial isolates obtained in this study from different patients 
were Pseudomonas spp (45%), Proteus spp (13.2%), Escherichia 
coli (23.7%), Klebsiella spp (21.5%), Staphylococcus aureus 
(31.2%), Staphylococcus epidermidis (3.1%), Staphylococcus 
saprophyticus (1.6%), and Streptococcus spp (4.7%).   
• Staphylococcus spp and Pseudomonas aeruginosa were the most 
common bacterial isolates causing wound infection in cancer 
patients. 
• Antibiotics tested, were found to be not effective antimicrobial 
agents against most isolates. 
• Gentamycin was the most antibacterial agent against both Gram-
positive and Gram-negative isolates.
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Recommendations 
Based on the results obtained in this study the following is 
recommended:  
• Microbiology lab should be established in Radiation and Isotope 
Center as soon as possible. 
• The entire staff especially health care workers should be well 
trained to deal with cancer patients to prevent or decrease the 
infections.  
• Further studies should be done to isolate and identity the common 
causes of infections and to evaluate the antimicrobial agent which 
are used in the treatments. 
•  If not possible to isolate and examine the antibiotics sensitivity of 
causative bacteria combination of antibiotics should be used to 
increase the effectiveness and to avoid development of drug 
resistance.  
• All attempts should be made to improve or eliminate the defect in 
host defense e.g. by improving nutritional status by adequate 
protein, vitamins and calories intake. 
•   Strict personal hygiene such as hand washing procedures with 
soap and antiseptic solutions is required and should be 
recommended for the health-care worker. 
• Laminar air flow units are clearly effective in providing a hygienic 
atmosphere for patients especially those with hematological 
malignancies. 
• Visitors and co-patients over crowds should be avoided. 
• Surveillance program has to be set-up for quality control and 
quality assurance, to detect and eliminate any infectious agents that 
may transmit between working staff, patients and hospital 
environments.  
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